FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Cella

Research Profile

Concepts & Ideas

Activities & Behaviors

Disorders

Procedures

Geographic Areas

United States

Chemicals & Drugs

Antineoplastic Agents

Co-author Network

Publications

TOP 3
Susan Magasi; Rajiv Mallick; Jyoti D Patel; Melissa L Johnson; Karen Kaiser; Edward H Kaplan; Thomas Lad; David Cella
Importance and relevance of pulmonary symptoms among patients receiving second- and third-line treatment for advanced non-small-cell lung cancer: support for the content validity of the 4-item pulmonary symptom index.
David Cella; C Chen; B Escudier; S Kim; B Rini; B Rosbrook; J Tarazi; H Bhattacharyya; Robert J Motzer
Patient-reported outcomes for axitinib vs sorafenib in metastatic renal cell carcinoma: phase III (AXIS) trial.
Lynne I Wagner; Kimberly Webster; Monika Aneja; Sara R Berg; David Cella; Mona Gandhi; Fay J Hlubocky; Mario Lacouture
The development of a Functional Assessment of Cancer Therapy (FACT) questionnaire to assess dermatologic symptoms associated with epidermal growth factor receptor inhibitors (FACT-EGFRI-18).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Cella (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Susan Magasi; Rajiv Mallick; Jyoti D Patel; Melissa L Johnson; Karen Kaiser; Edward H Kaplan; Thomas Lad; David Cella
Importance and relevance of pulmonary symptoms among patients receiving second- and third-line treatment for advanced non-small-cell lung cancer: support for the content validity of the 4-item pulmonary symptom index.
Clinical lung cancer 2013;14(3):245-53.
2013: David Cella; C Chen; B Escudier; S Kim; B Rini; B Rosbrook; J Tarazi; H Bhattacharyya; Robert J Motzer
Patient-reported outcomes for axitinib vs sorafenib in metastatic renal cell carcinoma: phase III (AXIS) trial.
British journal of cancer 2013;108(8):1571-8.
2013: Lynne I Wagner; Kimberly Webster; Monika Aneja; Sara R Berg; David Cella; Mona Gandhi; Fay J Hlubocky; Mario Lacouture
The development of a Functional Assessment of Cancer Therapy (FACT) questionnaire to assess dermatologic symptoms associated with epidermal growth factor receptor inhibitors (FACT-EGFRI-18).
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2013;21(4):1033-41.
2013: Stacy D Sanford; Jerry J Sweet; Lynne I Wagner; Jennifer L Beaumont; Zeeshan Butt; David Cella
Longitudinal prospective assessment of sleep quality: before, during, and after adjuvant chemotherapy for breast cancer.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2013;21(4):959-67.
2013: Paul A Pilkonis; John M Salsman; Nicholas Zill; Zeeshan Butt; Seung W Choi; Jill M Cyranowski; Morgen A R Kelly; Sarah S Knox; Suzanne M Lawrence; Tara L Moore; David Cella
Assessment of self-reported negative affect in the NIH Toolbox.
Psychiatry research 2013;206(1):88-97.
2013: John M Salsman; Catherine M Stoney; Nicholas Zill; Rita K Bode; Pim Brouwers; Zeeshan Butt; Seung W Choi; Jill M Cyranowski; James W Griffith; Hugh C Hendrie; Morgen A R Kelly; Sarah S Knox; Mary Jo Kupst; Jin-Shei Lai; Paul A Pilkonis; David Cella
Emotion assessment using the NIH Toolbox.
Neurology 2013;80(11 Suppl 3):S76-86.
2013: Jill M Cyranowski; Morgen A R Kelly; Paul A Pilkonis; John M Salsman; Nicholas Zill; Rita Bode; Zeeshan Butt; David Cella
Assessing social support, companionship, and distress: National Institute of Health (NIH) Toolbox Adult Social Relationship Scales.
Health psychology : official journal of the Division of Health Psychology, American Psychological Association 2013;32(3):293-301.
2013: David Cella; Jean Kutner; Nikki Neubauer; Jay Thomas; Michael V Seiden
The FACIT-AI, a new tool for assessing symptoms associated with malignant ascites.
Gynecologic oncology 2013;128(2):187-90.
2013: Lisa M Hess; Bradley J Monk; Lari Wenzel; William E Brady; David E Cohn; Laura Havrilesky; David Cella
Comparison of methods to estimate health state utilities for ovarian cancer using quality of life data: a Gynecologic Oncology Group study.
Gynecologic oncology 2013;128(2):175-80.
2013: Charles S Cleeland; Amylou C Dueck; Nora A Janjan; Astra M Liepa; Rajiv Mallick; Ann O'Mara; Jay D Pearson; Jeff A Sloan; Yasuhiro Torigoe; Xin Shelley Wang; Loretta A Williams; Jeanie F Woodruff; David Cella; Connie Chen
Recommendations for including multiple symptoms as endpoints in cancer clinical trials: a report from the ASCPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task Force.
Cancer 2013;119(2):411-20.
2013: Zeeshan Butt; Connie Chen; John Peipert; Kimberly Webster; David Cella
General population norms for the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI).
Cancer 2013;119(2):429-37.
2013: Zeeshan Butt; Allen W Heinemann; Jin-Shei Lai; Deepa Rao; Alex Bill; David Cella
Measurement of fatigue in cancer, stroke, and HIV using the Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-F) scale.
Journal of psychosomatic research 2013;74(1):64-8.
2012: David Cella; Du Hongyan; Sally E Jensen; Jin-Shei Lai; Steven Rosen; Martin S Tallman; Kimberly Webster; Susan Yount
Measuring health-related quality of life in leukemia: the Functional Assessment of Cancer Therapy--Leukemia (FACT-Leu) questionnaire.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2012;15(8):1051-8.
2012: Zeeshan Butt; Amy P Abernethy; Jennifer L Beaumont; Al B Benson; Neehar D Parikh; Sarah K Rosenbloom; Karen L Syrjala; David Cella
Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers: the National Comprehensive Cancer Network Functional Assessment of Cancer Therapy (NCCN-FACT) Hepatobiliary-Pancreatic Symptom Index (NFHSI).
Cancer 2012;118(23):5997-6004.
2012: John M Salsman; Sofia F Garcia; Jin-Shei Lai; David Cella
Have a little faith: measuring the impact of illness on positive and negative aspects of faith.
Psycho-oncology 2012;21(12):1357-61.
2012: Ricardo Cruciani; Bilal Ansari; David Cella; Judith Manola; Jenny J Zhang; Michael J Fisch
L-carnitine supplementation for the management of fatigue in patients with cancer: an eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(31):3864-9.
2012: Sally E Jensen; Allen W Heinemann; Michael M Abecassis; Talia Baker; Alex Bill; Zeeshan Butt; David Cella; Gregory A Dumanian
Quality of life considerations in upper limb transplantation: review and future directions.
The Journal of hand surgery 2012;37(10):2126-35.
2012: David Cella; Irina Proskorovsky; Feng Pan
Approach to fixing the discrepancy found in the Wu et al. FACT-P to EQ-5D questionnaire mapping algorithm.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2012;15(5):783-4; author reply 785.
2012: Lynne I Wagner; Matthias Weiss; Rafael Fonseca; Phillip Greipp; Michael Katz; Don Robinson; David Cella
Content development for the Functional Assessment of Cancer Therapy-Multiple Myeloma (FACT-MM): use of qualitative and quantitative methods for scale construction.
Journal of pain and symptom management 2012;43(6):1094-104.
2012: Michael J Fisch; Ju-Whei Lee; Judith B Manola; Worta McCaskill-Stevens; Tito R Mendoza; Lori M Minasian; Lynne I Wagner; Matthias Weiss; David Cella; Victor T Chang; Charles S Cleeland
Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(16):1980-8.
2012: Zeeshan Butt; Daniela Ladner; Neehar D Parikh; Anton I Skaro; David Cella
Quality of life, risk assessment, and safety research in liver transplantation: new frontiers in health services and outcomes research.
Current opinion in organ transplantation 2012;17(3):241-7.
2012: Susan Magasi; Dennis Revicki; Gery Ryan; CLAIRE SNYDER; Maarten Boers; Meryl Brod; Ron D Hays; William Lenderking; David Cella
Content validity of patient-reported outcome measures: perspectives from a PROMIS meeting.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2012;21(5):739-46.
2012: George M Rodgers; Joseph Rosenthal; Rowena N Schwartz; Gerald Soff; Richard S Stein; Gordana Vlahovic; Pamela Sue Becker; Morey Blinder; David Cella; Asher Chanan-Khan; Charles Cleeland; Peter F. Coccia; Benjamin Djulbegovic; Jeffrey A Gilreath; Eric H Kraut; Ursula Matulonis; Michael Millenson; Denise Reinke; Alva B Weir
Cancer- and chemotherapy-induced anemia.
Journal of the National Comprehensive Cancer Network : JNCCN 2012;10(5):628-53.
2012: Melanie A Dirks; Margaret Briggs-Gowan; David Cella; Andres De Los Reyes; Lauren S Wakschlag
Annual research review: embracing not erasing contextual variability in children's behavior--theory and utility in the selection and use of methods and informants in developmental psychopathology.
Journal of child psychology and psychiatry, and allied disciplines 2012;53(5):558-74.
2012: Robert J Motzer; Mark R Olsen; John A Thompson; Olga Valota; George Wilding; Jinyu Yuan; Neeraj Agarwal; Akintunde Bello; John M Burke; David Cella; William J Edenfield; Subramanian Hariharan; Gary R Hudes; Thomas E Hutson; Beata Korytowsky; Bridget Martell; Robert A Figlin
Randomized phase II trial of sunitinib on an intermittent versus continuous dosing schedule as first-line therapy for advanced renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(12):1371-7.
2012: Richard C Gershon; Jin-Shei Lai; Deborah Miller; Claudia Moy; Amy Peterman; Tom Bleck; Rita Bode; Seung Choi; David Cella
Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2012;21(3):475-86.
2012: Jin-Shei Lai; Sarah Rosenbloom; John M Salsman; Sofia F Garcia; David Cella
The psychosocial impact of cancer: evidence in support of independent general positive and negative components.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2012;21(2):195-207.
2012: David Cella; C Charbonneau; M D Michaelson; A G Bushmakin; J C Cappelleri; Robert J Motzer
Baseline quality of life as a prognostic survival tool in patients receiving sunitinib for metastatic renal cell carcinoma.
British journal of cancer 2012;106(4):646-50.
2012: John M Salsman; Jennifer L Beaumont; Marla L Clayman; Steven M Grunberg; Diane Paul; Miriam Rogers; David Cella
Communicating about chemotherapy-induced nausea and vomiting: a comparison of patient and provider perspectives.
Journal of the National Comprehensive Cancer Network : JNCCN 2012;10(2):149-57.
2012: Allen W Heinemann; Sarah Rosenbloom; Rita K Bode; David Cella
Developing an emotional distress item bank for cancer patients.
Journal of applied measurement 2012;13(1):97-113.
2012: Sofia F Garcia; Douglas Merkel; Deepa Rao; Sarah K Rosenbloom; Jamie H Von Roenn; Jennifer L Beaumont; David Cella
Priority symptoms in advanced breast cancer: development and initial validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16).
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2012;15(1):183-90.
2012: Dinesh Khanna; Paul Maranian; Nan Rothrock; Brennan Spiegel; Amber Bechtel; David Cella; Phil J Clements; Daniel E Furst; Richard Gershon; Puja P Khanna; Ron D Hays
Feasibility and construct validity of PROMIS and "legacy" instruments in an academic scleroderma clinic.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2012;15(1):128-34.
2011: Brian I Rini; Brad Rosbrook; Igor G Rusakov; Cezary Szczylik; Jamal Tarazi; Piotr Tomczak; Hirotsugu Uemura; Sylvie Negrier; Yen-Chuan Ou; Daniel Castellano; David Cella; Connie Chen; Bernard Escudier; Vera A Gorbunova; Martin E Gore; Thomas E Hutson; Andrey Kaprin; Sinil Kim; Ho Yeong Lim; M Dror Michaelson; Robert J Motzer
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.
Lancet 2011;378(9807):1931-9.
2011: Adam Carle; David Cella; Seung W Choi; Paul K Crane; S McKay Curtis; Jonathan Gruhl; Jin-Shei Lai; Shubhabrata Mukherjee; Steven P Reise; Jeanne A Teresi; David Thissen; Eric J Wu; Li Cai; Ron D Hays
Advancing PROMIS's methodology: results of the Third Patient-Reported Outcomes Measurement Information System (PROMIS(®)) Psychometric Summit.
Expert review of pharmacoeconomics & outcomes research 2011;11(6):677-84.
2011: David Cella; Lynne Wagner; Molin Wang; Kathy Miller
Survival-adjusted health-related quality of life (HRQL) among patients with metastatic breast cancer receiving paclitaxel plus bevacizumab versus paclitaxel alone: results from Eastern Cooperative Oncology Group Study 2100 (E2100).
Breast cancer research and treatment 2011;130(3):855-61.
2011: Monique Hinchcliff; Sofia Podlusky; Krishna Thavarajah; John Varga; Jennifer L Beaumont; Mary Carns; Rowland W Chang; Anh Chung; David Cella
Validity of two new patient-reported outcome measures in systemic sclerosis: Patient-Reported Outcomes Measurement Information System 29-item Health Profile and Functional Assessment of Chronic Illness Therapy-Dyspnea short form.
Arthritis care & research 2011;63(11):1620-8.
2011: Patrick J Loehrer; Ramesh K Ramanathan; Lynne Wagner; Steven R Alberts; Joanna M Brell; Higinia R. Cardenes; David Cella; Christopher H Crane; Yang Feng; Patrick Flynn; Al B Benson
Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(31):4105-12.
2011: David S Tulsky; David Victorson; Dagmar Amtmann; Allen W Heinemann; Pamela A Kisala; Denise G Tate; David Cella
Developing a contemporary patient-reported outcomes measure for spinal cord injury.
Archives of physical medicine and rehabilitation 2011;92(10 Suppl):S44-51.
2011: David Cella; Jin-Shei Lai; Deborah Miller; Cindy Nowinski; Amy Peterman; David Victorson; Claudia Moy
The neurology quality-of-life measurement initiative.
Archives of physical medicine and rehabilitation 2011;92(10 Suppl):S28-36.
2011: Jin-Shei Lai; David Cella; Seung Choi; Christopher Christodoulou; Richard Gershon; Doerte U Junghaenel; Arthur Stone
How item banks and their application can influence measurement practice in rehabilitation medicine: a PROMIS fatigue item bank example.
Archives of physical medicine and rehabilitation 2011;92(10 Suppl):S20-7.
2011: Dagmar Amtmann; Karon F Cook; Kurt L Johnson; David Cella
The PROMIS initiative: involvement of rehabilitation stakeholders in development and examples of applications in rehabilitation research.
Archives of physical medicine and rehabilitation 2011;92(10 Suppl):S12-9.
2011: David S Tulsky; Noelle E Carlozzi; David Cella
Advances in outcomes measurement in rehabilitation medicine: current initiatives from the National Institutes of Health and the National Institute on Disability and Rehabilitation Research.
Archives of physical medicine and rehabilitation 2011;92(10 Suppl):S1-6.
2011: Paul A Pilkonis; Steven P Reise; William T Riley; Angela M Stover; David Cella; Seung W Choi
Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS®): depression, anxiety, and anger.
Assessment 2011;18(3):263-83.
2011: David Cella; Jin-Shei Lai; Arthur Stone
Self-reported fatigue: one dimension or more? Lessons from the Functional Assessment of Chronic Illness Therapy--Fatigue (FACIT-F) questionnaire.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2011;19(9):1441-50.
2011: David E Victorson; Jennifer L Beaumont; Sarah K Rosenbloom; Daniel Shevrin; David Cella
Efficient assessment of the most important symptoms in advanced prostate cancer: the NCCN/FACT-P Symptom Index.
Psycho-oncology 2011;20(9):977-83.
2011: Jennifer L Beaumont; Christine L Baker; Hemal Shah; Jun Su; David Victorson; Katy Wortman; David Cella
Examining web equivalence and risk factor sensitivity of the COPD population screener.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2011;14(4):506-12.
2011: John M Salsman; Kathleen J Yost; Dee W West; David Cella
Spiritual well-being and health-related quality of life in colorectal cancer: a multi-site examination of the role of personal meaning.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2011;19(6):757-64.
2011: Kathleen J Yost; David T Eton; Sofia F Garcia; David Cella
Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients.
Journal of clinical epidemiology 2011;64(5):507-16.
2011: Jin-Shei Lai; Jennifer L Beaumont; Sarika Ogale; Paul Brunetta; David Cella
Validation of the functional assessment of chronic illness therapy-fatigue scale in patients with moderately to severely active systemic lupus erythematosus, participating in a clinical trial.
The Journal of rheumatology 2011;38(4):672-9.
2011: Susan Yount; Seung W Choi; David Victorson; Bernice Ruo; David Cella; Susan Anton; Alan Hamilton
Brief, valid measures of dyspnea and related functional limitations in chronic obstructive pulmonary disease (COPD).
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2011;14(2):307-15.
2011: Seung W Choi; David E Victorson; Susan Yount; Susan Anton; David Cella
Development of a conceptual framework and calibrated item banks to measure patient-reported dyspnea severity and related functional limitations.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2011;14(2):291-306.
2011: David Cella; Debra Hampton; Paul B Jacobsen; Diane Paul; Sarah K Rosenbloom; Karen Syrjala; Amy P Abernethy; Jennifer L Beaumont; Susan E Yount; Jamie H Von Roenn
Development and validation of 11 symptom indexes to evaluate response to chemotherapy for advanced cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2011;9(3):268-78.
2011: Jin-Shei Lai; Frank Zelko; Zeeshan Butt; David Cella; Mark W Kieran; Kevin R Krull; Susan Magasi; Stewart Goldman
Parent-perceived child cognitive function: results from a sample drawn from the US general population.
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2011;27(2):285-93.
2011: Jennifer L Beaumont; Zeeshan Butt; Jeanfrancois Baladi; Robert J Motzer; Tomas Haas; Norbert Hollaender; Andrea Kay; David Cella
Patient-reported outcomes in a phase iii study of everolimus versus placebo in patients with metastatic carcinoma of the kidney that has progressed on vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy.
The oncologist 2011;16(5):632-40.
2010: David Cella; Helen Huang; Howard D Homesley; Anthony Montag; Ritu Salani; Koen De Geest; Roger Lee; Nick M Spirtos
Patient-reported peripheral neuropathy of doxorubicin and cisplatin with and without paclitaxel in the treatment of advanced endometrial cancer: Results from GOG 184.
Gynecologic oncology 2010;119(3):538-42.
2010: David Cella; Helen Q Huang; Bradley J Monk; Lari Wenzel; Jo Benda; D Scott McMeekin; David E Cohn; Lois Ramondetta; Cecelia H Boardman
Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: a Gynecologic Oncology Group study.
Gynecologic oncology 2010;119(3):531-7.
2010: John R Wingard; I-Chan Huang; Kathleen A Sobocinski; Michael A Andrykowski; David Cella; J Douglas Rizzo; Marianne Brady; Mary M Horowitz; Michelle M Bishop
Factors associated with self-reported physical and mental health after hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(12):1682-92.
2010: Honghu Liu; David Cella; Richard Gershon; Jie Shen; Leo S Morales; William Riley; Ron D Hays
Representativeness of the Patient-Reported Outcomes Measurement Information System Internet panel.
Journal of clinical epidemiology 2010;63(11):1169-78.
2010: Nan E Rothrock; Ron D Hays; Karen Spritzer; Susan Yount; William Riley; David Cella
Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS).
Journal of clinical epidemiology 2010;63(11):1195-204.
2010: David Cella; William Riley; Arthur Stone; Nan Rothrock; Bryce B Reeve; Susan Yount; Dagmar Amtmann; Rita K Bode; Daniel Buysse; Seung Choi; Karon Cook; Robert F DeVellis; Darren DeWalt; James F Fries; Richard Gershon; Elizabeth A Hahn; Jin-Shei Lai; Paul A Pilkonis; Dennis Revicki; Matthias Rose; Kevin P Weinfurt; Ron Hays
The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008.
Journal of clinical epidemiology 2010;63(11):1179-94.
2010: D Rao; N Gela; E M Daley; R Kattezham; G Rodriguez; David Cella
Developing a measure of health-related quality of life for women with cervical dysplasia resulting from human papillomavirus infection.
International journal of STD & AIDS 2010;21(10):697-701.
2010: Ron D Hays; Rita Bode; Nan Rothrock; William Riley; David Cella; Richard Gershon
The impact of next and back buttons on time to complete and measurement reliability in computer-based surveys.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2010;19(8):1181-4.
2010: Rita K Bode; Elizabeth A Hahn; Robert F DeVellis; David Cella
Measuring participation: the Patient-Reported Outcomes Measurement Information System experience.
Archives of physical medicine and rehabilitation 2010;91(9 Suppl):S60-5.
2010: Elizabeth A Hahn; Robert F DeVellis; Rita K Bode; Sofia F Garcia; Liana D Castel; Susan V Eisen; Hayden B Bosworth; Allen W Heinemann; Nan Rothrock; David Cella
Measuring social health in the patient-reported outcomes measurement information system (PROMIS): item bank development and testing.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2010;19(7):1035-44.
2010: Barbara F Piper; David Cella
Cancer-related fatigue: definitions and clinical subtypes.
Journal of the National Comprehensive Cancer Network : JNCCN 2010;8(8):958-66.
2010: Ann M Berger; Amy Pickar Abernethy; Ashley Atkinson; Andrea M Barsevick; William Breitbart; David Cella; Bernadine Cimprich; Charles Cleeland; Mario A Eisenberger; Carmen P Escalante; Paul B Jacobsen; Phyllis Kaldor; Jennifer A Ligibel; Barbara A Murphy; Tracey O'Connor; William F Pirl; Eve Rodler; Hope S Rugo; Jay Thomas; Lynne I Wagner
Cancer-related fatigue.
Journal of the National Comprehensive Cancer Network : JNCCN 2010;8(8):904-31.
2010: Bernice Ruo; Seung W Choi; David W Baker; Kathleen L Grady; David Cella
Development and validation of a computer adaptive test for measuring dyspnea in heart failure.
Journal of cardiac failure 2010;16(8):659-68.
2010: Zeeshan Butt; Arati V Rao; Jin-Shei Lai; Amy P Abernethy; Sarah K Rosenbloom; David Cella
Age-associated differences in fatigue among patients with cancer.
Journal of pain and symptom management 2010;40(2):217-23.
2010: Elizabeth A Hahn; Hongyan Du; Sofia F Garcia; David Cella
Patient attitudes and preferences regarding literacy screening in ambulatory cancer care clinics.
Patient related outcome measures 2010;1():19-27.
2010: Dagmar Amtmann; Karon F Cook; Mark P Jensen; Wen-Hung Chen; Seung Choi; D Revicki; David Cella; Nan Rothrock; Francis Keefe; Leigh Callahan; Jin-Shei Lai
Development of a PROMIS item bank to measure pain interference.
Pain 2010;150(1):173-82.
2010: Elizabeth A Hahn; Hongyan Du; Sofia F Garcia; Seung W Choi; Jin-Shei Lai; David Victorson; David Cella
Literacy-fair measurement of health-related quality of life will facilitate comparative effectiveness research in Spanish-speaking cancer outpatients.
Medical care 2010;48(6 Suppl):S75-82.
2010: Eleanor Smith; Jin-Shei Lai; David Cella
Building a measure of fatigue: the functional assessment of Chronic Illness Therapy Fatigue Scale.
PM & R : the journal of injury, function, and rehabilitation 2010;2(5):359-63.
2010: Kristi D Graves; Lari Wenzel; Marc D Schwartz; George Luta; Paul Wileyto; steven narod; Beth N Peshkin; Alfred Marcus; David Cella; Susan Powell Emsbo; Denise Barnes; Chanita Hughes Halbert
Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(3):648-54.
2010: David Cella; M D Michaelson; A G Bushmakin; J C Cappelleri; C Charbonneau; S T Kim; J Z Li; Robert J Motzer
Health-related quality of life in patients with metastatic renal cell carcinoma treated with sunitinib vs interferon-alpha in a phase III trial: final results and geographical analysis.
British journal of cancer 2010;102(4):658-64.
2010: Richard C Gershon; David Cella; Nathan Fox; Richard J Havlik; Hugh C Hendrie; Molly V Wagster
Assessment of neurological and behavioural function: the NIH Toolbox.
Lancet neurology 2010;9(2):138-9.
2010: Seung W Choi; Steven P Reise; Paul A Pilkonis; Ron D Hays; David Cella
Efficiency of static and computer adaptive short forms compared to full-length measures of depressive symptoms.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2010;19(1):125-36.
2010: Richard C Gershon; Nan Rothrock; Rachel Hanrahan; Michael Bass; David Cella
The use of PROMIS and assessment center to deliver patient-reported outcome measures in clinical research.
Journal of applied measurement 2010;11(3):304-14.
2010: David Cella; Hélène Gilet; Muriel Viala-Danten; Katrien Peeters; Dominique Dubois; Silas Martin
Effects of etravirine versus placebo on health-related quality of life in treatment-experienced HIV patients as measured by the functional assessment of human immunodeficiency virus infection (FAHI) questionnaire in the DUET trials.
HIV clinical trials 2010;11(1):18-27.
2009: David Cella
Quality of life in patients with metastatic renal cell carcinoma: the importance of patient-reported outcomes.
Cancer treatment reviews 2009;35(8):733-7.
2009: Alice B Kornblith; Helen Q Huang; Joan L Walker; Nick M Spirtos; Jacob Rotmensch; David Cella
Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(32):5337-42.
2009: Robert L Askew; Yan Xing; J Lynn Palmer; David Cella; Lemuel A Moye; Janice N Cormier
Evaluating minimal important differences for the FACT-Melanoma quality of life questionnaire.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2009;12(8):1144-50.
2009: Barbara A Murphy; Jennifer L Beaumont; John Isitt; Adam S Garden; Clement K Gwede; Andy M Trotti; Ruby F Meredith; Joel B Epstein; Quynh-Thu Le; David M. Brizel; Lisa A Bellm; Nancy Wells; David Cella
Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy.
Journal of pain and symptom management 2009;38(4):522-32.
2009: Peter L Greenberg; Zhuoxin Sun; Kenneth B Miller; John M Bennett; Martin S Tallman; Gordon Dewald; Elisabeth Paietta; Richard van der Jagt; Jessie G. Houston; Mary L Thomas; David Cella; Jacob M Rowe
Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996).
Blood 2009;114(12):2393-400.
2009: James F Fries; David Cella; Matthias Rose; Eswar Krishnan; Bonnie Bruce
Progress in assessing physical function in arthritis: PROMIS short forms and computerized adaptive testing.
The Journal of rheumatology 2009;36(9):2061-6.
2009: Daniela Matei; Anna M Miller; Patrick O Monahan; David Gershenson; Qianqian Zhao; David Cella; Victoria L Champion; Stephen D Williams
Chronic physical effects and health care utilization in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(25):4142-9.
2009: Ron D Hays; Jakob B Bjorner; Dennis A Revicki; Karen L Spritzer; David Cella
Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2009;18(7):873-80.
2009: A Simon Pickard; James W Shaw; Hsiang-Wen Lin; Peter C Trask; Neil Aaronson; Todd A Lee; David Cella
A patient-based utility measure of health for clinical trials of cancer therapy based on the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2009;12(6):977-88.
2009: David E Victorson; Susan Anton; Alan Hamilton; Susan Yount; David Cella
A conceptual model of the experience of dyspnea and functional limitations in chronic obstructive pulmonary disease.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2009;12(6):1018-25.
2009: Jin-Shei Lai; Karon Cook; Arthur Stone; Jennifer Beaumont; David Cella
Classical test theory and item response theory/Rasch model to assess differences between patient-reported fatigue using 7-day and 4-week recall periods.
Journal of clinical epidemiology 2009;62(9):991-7.
2009: Elizabeth Poplin; Yang Feng; Jordan Berlin; Mace L Rothenberg; Howard Hochster; Edith Mitchell; Steven Alberts; Peter O'Dwyer; Daniel Haller; Paul Catalano; David Cella; Al Bowen Benson
Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(23):3778-85.
2009: Dennis A Revicki; Ariane K Kawata; Neesha Harnam; Wen-Hung Chen; Ron D Hays; David Cella
Predicting EuroQol (EQ-5D) scores from the patient-reported outcomes measurement information system (PROMIS) global items and domain item banks in a United States sample.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2009;18(6):783-91.
2009: Reuben Broom; Hongyan Du; Mark Clemons; David Eton; George Dranitsaris; Christine Simmons; Wei Ooi; David Cella
Switching breast cancer patients with progressive bone metastases to third-generation bisphosphonates: measuring impact using the Functional Assessment of Cancer Therapy-Bone Pain.
Journal of pain and symptom management 2009;38(2):244-57.
2009: Deepa Rao; Zeeshan Butt; Sarah Rosenbloom; Don Robinson; Jamie H Von Roenn; Timothy M Kuzel; David Cella
A Comparison of the Renal Cell Carcinoma-Symptom Index (RCC-SI) and the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI).
Journal of pain and symptom management 2009;38(2):291-8.
2009: Jin-Shei Lai; Zeeshan Butt; Lynne Wagner; Jerry J Sweet; Jennifer L Beaumont; Janette Vardy; Paul B Jacobsen; Pamela Shapiro; Sheri R Jacobs; David Cella
Evaluating the dimensionality of perceived cognitive function.
Journal of pain and symptom management 2009;37(6):982-95.
2009: Deepa Rao; Seung W Choi; David Victorson; Rita K Bode; Amy Peterman; Allen W Heinemann; David Cella
Measuring stigma across neurological conditions: the development of the stigma scale for chronic illness (SSCI).
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2009;18(5):585-95.
2009: Michael C F Tong; Phoebe S Y Lo; Kam Hung Wong; Rebecca M W Yeung; C Andrew van Hasselt; Sonya Eremenco; David Cella
Development and validation of the functional assessment of cancer therapy nasopharyngeal cancer subscale.
Head & neck 2009;31(6):738-47.
2009: Monika Janda; Tracey DiSipio; Cameron Hurst; David Cella; Beth Newman
The Queensland Cancer Risk Study: general population norms for the Functional Assessment of Cancer Therapy-General (FACT-G).
Psycho-oncology 2009;18(6):606-14.
2009: D Robinson; N Zhao; T Gathany; L-L Kim; David Cella; D Revicki
Health perceptions and clinical characteristics of relapsing-remitting multiple sclerosis patients: baseline data from an international clinical trial.
Current medical research and opinion 2009;25(5):1121-30.
2009: Bernard Escudier; Cezary Szczylik; Thomas E Hutson; Tomasz Demkow; Michael Staehler; Frédéric Rolland; Sylvie Negrier; Nicole Laferriere; Urban J Scheuring; David Cella; Sonalee Shah; Ronald M Bukowski
Randomized phase II trial of first-line treatment with sorafenib versus interferon Alfa-2a in patients with metastatic renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(8):1280-9.
2009: David Cella; Joseph C Cappelleri; Andrew Bushmakin; Claudie Charbonneau; Jim Z Li; Sindy T Kim; Isan Chen; M Dror Michaelson; Robert J Motzer
Quality of life predicts progression-free survival in patients with metastatic renal cell carcinoma treated with sunitinib versus interferon alfa.
Journal of oncology practice / American Society of Clinical Oncology 2009;5(2):66-70.
2009: Howard D Homesley; Virginia Filiaci; Susan K Gibbons; Harry J Long; David Cella; Nick M Spirtos; Robert Thomas Morris; Koen DeGeest; Roger Lee; Anthony Montag
A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study.
Gynecologic oncology 2009;112(3):543-52.
2009: Susan D Mathias; Sue K Gao; Mark Rutstein; CLAIRE SNYDER; Albert W Wu; David Cella
Evaluating clinically meaningful change on the ITP-PAQ: preliminary estimates of minimal important differences.
Current medical research and opinion 2009;25(2):375-83.
2009: David Cella; Michael B Nichol; David T Eton; Joel B Nelson; Parvez Mulani
Estimating clinically meaningful changes for the Functional Assessment of Cancer Therapy--Prostate: results from a clinical trial of patients with metastatic hormone-refractory prostate cancer.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2009;12(1):124-9.
2008: Jack Cuzick; Ivana Sestak; David Cella; Lesley Fallowfield
Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial.
The lancet oncology 2008;9(12):1143-8.
2008: David Victorson; Joshua Barocas; Juliette Song; David Cella
Reliability across studies from the functional assessment of cancer therapy-general (FACT-G) and its subscales: a reliability generalization.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2008;17(9):1137-46.
2008: Deepa Rao; Scott Debb; David Blitz; Seung W Choi; David Cella
Racial/Ethnic differences in the health-related quality of life of cancer patients.
Journal of pain and symptom management 2008;36(5):488-96.
2008: CLAIRE SNYDER; Susan D Mathias; David Cella; John J Isitt; Albert W Wu; Joan Young
Health-related quality of life of immune thrombocytopenic purpura patients: results from a web-based survey.
Current medical research and opinion 2008;24(10):2767-76.
2008: David Cella; Hema N Viswanathan; Ron D Hays; Tito R Mendoza; Kevin D Stein; David J Pasta; Aimee J Foreman; Saroj Vadhan-Raj; Joel D Kallich
Development of a fatigue and functional impact scale in anemic cancer patients receiving chemotherapy.
Cancer 2008;113(6):1480-8.
2008: Hongyan Du; Veronica Valenzuela; Patricia Diaz; David Cella; Elizabeth A Hahn
Factors affecting enrollment in literacy studies for English- and Spanish-speaking cancer patients.
Statistics in medicine 2008;27(20):4119-31.
2008: Fairooz Kabbinavar; Joel F Wallace; Eric Holmgren; Jing Yi; David Cella; Kathleen J Yost; Herbert I Hurwitz
Health-related quality of life impact of bevacizumab when combined with irinotecan, 5-fluorouracil, and leucovorin or 5-fluorouracil and leucovorin for metastatic colorectal cancer.
The oncologist 2008;13(9):1021-9.
2008: David E Victorson; David Cella; Marc A Judson
Quality of life evaluation in sarcoidosis: current status and future directions.
Current opinion in pulmonary medicine 2008;14(5):470-7.
2008: David Cella; Jim Z Li; Joseph C Cappelleri; Andrew Bushmakin; Claudie Charbonneau; Sindy T Kim; Isan Chen; Robert J Motzer
Quality of life in patients with metastatic renal cell carcinoma treated with sunitinib or interferon alfa: results from a phase III randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(22):3763-9.
2008: Dennis C Turk; Robert H Dworkin; D Revicki; Gale Harding; Laurie B Burke; David Cella; Charles S Cleeland; Penney Cowan; John T Farrar; Sharon Hertz; Mitchell B Max; Bob A Rappaport
Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain.
Pain 2008;137(2):276-85.
2008: Elizabeth B Lynch; Zeeshan Butt; Allen Heinemann; David Victorson; Cindy J Nowinski; Lori Perez; David Cella
A qualitative study of quality of life after stroke: the importance of social relationships.
Journal of rehabilitation medicine : official journal of the UEMS European Board of Physical and Rehabilitation Medicine 2008;40(7):518-23.
2008: Donald W Robinson; Debra F Eisenberg; David Cella; Ning Zhao; Carla de Boer; Mark DeWitte
The prognostic significance of patient-reported outcomes in pancreatic cancer cachexia.
The journal of supportive oncology 2008;6(6):283-90.
2008: David Cella; Jyoti D Patel
Improving health-related quality of life in non-small-cell lung cancer with current treatment options.
Clinical lung cancer 2008;9(4):206-12.
2008: George M Rodgers; Pamela Sue Becker; Charles L Bennett; David Cella; Asher Chanan-Khan; Carolyn Chesney; Charles S Cleeland; Peter F. Coccia; Benjamin Djulbegovic; Jennifer L Garst; Jeffrey A Gilreath; Eric H Kraut; Weei-Chin Lin; Ursula Matulonis; Michael Millenson; Denise Reinke; Joseph Rosenthal; Paul Sabbatini; Rowena N Schwartz; Richard S Stein; Ravi Vij
Cancer- and chemotherapy-induced anemia.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(6):536-64.
2008: Lari Wenzel; Helen Q Huang; David Cella; Joan L Walker; Deborah K Armstrong
Validation of FACT/GOG-AD subscale for ovarian cancer-related abdominal discomfort: a Gynecologic Oncology Group study.
Gynecologic oncology 2008;110(1):60-4.
2008: David H Henry; Hema N Viswanathan; Eric P Elkin; Shana Traina; Shawn Wade; David Cella
Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2008;16(7):791-801.
2008: David Cella; Stephanie R Land; Chih-Hung Chang; Richard Day; Joseph P Costantino; Norman Wolmark; Patricia Anne Ganz
Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women.
Breast cancer research and treatment 2008;109(3):515-26.
2008: Janice N Cormier; Merrick I Ross; jeffrey gershenwald; Jeffrey E Lee; Paul F Mansfield; Luis H Camacho; Kevin Kim; Kimberly Webster; David Cella; J Lynn Palmer
Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaire.
Cancer 2008;112(10):2249-57.
2008: Zeeshan Butt; Sarah K Rosenbloom; Amy P Abernethy; Jennifer L Beaumont; Diane Paul; Debra Hampton; Paul B Jacobsen; Karen L Syrjala; Jamie H Von Roenn; David Cella
Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(5):448-55.
2008: Zeeshan Butt; Susan E Yount; Juan Carlos Caicedo; Michael M Abecassis; David Cella
Quality of life assessment in renal transplant: review and future directions.
Clinical transplantation 2008;22(3):292-303.
2008: George M Rodgers; Michael Auerbach; David Cella; Glenn M Chertow; Daniel W Coyne; John A Glaspy; David H Henry
High-molecular weight iron dextran: a wolf in sheep's clothing?
Journal of the American Society of Nephrology : JASN 2008;19(5):833-4.
2008: Henning Krampe; Claudia Bartels; David Victorson; Craig K Enders; Jennifer Beaumont; David Cella; Hannelore Ehrenreich
The influence of personality factors on disease progression and health-related quality of life in people with ALS.
Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 2008;9(2):99-107.
2008: Elizabeth A Hahn; Deepa Rao; David Cella; Seung W Choi
Comparability of interview- and self-administration of the Functional Assessment of Cancer Therapy-General (FACT-G) in English- and Spanish-speaking ambulatory cancer patients.
Medical care 2008;46(4):423-31.
2008: Kimberly M Davis; Jin-Shei Lai; Elizabeth A Hahn; David Cella
Conducting routine fatigue assessments for use in clinical oncology practice: patient and provider perspectives.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2008;16(4):379-86.
2008: Rogerio Lilenbaum; John Cashy; Thomas A Hensing; Susan Young; David Cella
Prevalence of poor performance status in lung cancer patients: implications for research.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(2):125-9.
2008: Dennis Revicki; Ron Hays; David Cella; Jeff Sloan
Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes.
Journal of clinical epidemiology 2008;61(2):102-9.
2008: Robert H Dworkin; Dennis C Turk; Kathleen W Wyrwich; Dorcas Beaton; Charles S Cleeland; John T Farrar; Jennifer Haythornthwaite; Mark P Jensen; Robert D Kerns; Deborah N Ader; Nancy Brandenburg; Laurie B Burke; David Cella; Julie Chandler; Penny Cowan; Rozalina Dimitrova; Ray Dionne; Sharon Hertz; Alejandro R Jadad; Nathaniel P Katz; Henrik Kehlet; Lynn D Kramer; Donald C Manning; Cynthia McCormick; Michael P McDermott; Henry J McQuay; Sanjay Patel; Linda Porter; Steve Quessy; Bob A Rappaport; Christine Rauschkolb; Dennis A Revicki; Margaret Rothman; Kenneth E Schmader; Brett R Stacey; JOSEPH STAUFFER; Thorsten von Stein; Richard E White; James Witter; Stojan Zavisic
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations.
The journal of pain : official journal of the American Pain Society 2008;9(2):105-21.
2008: Zeeshan Butt; Lynne I Wagner; Jennifer L Beaumont; Judith A Paice; Joshua Straus; Amy Peterman; George Carro; Jamie H Von Roenn; Dan Shevrin; David Cella
Longitudinal screening and management of fatigue, pain, and emotional distress associated with cancer therapy.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2008;16(2):151-9.
2008: Patrick O Monahan; Victoria L Champion; Qianqian Zhao; Anna M Miller; David Gershenson; Stephen D Williams; David Cella
Case-control comparison of quality of life in long-term ovarian germ cell tumor survivors: a gynecologic oncology group study.
Journal of psychosocial oncology 2008;26(3):19-42.
2008: David Cella; David T Eton; Thomas A Hensing; Gregory A Masters; Bhash Parasuraman
Relationship between symptom change, objective tumor measurements, and performance status during chemotherapy for advanced lung cancer.
Clinical lung cancer 2008;9(1):51-8.
2008: Susan D Mathias; Sue K Gao; Kimberly L Miller; David Cella; CLAIRE SNYDER; Ralph Turner; Albert W Wu; James B Bussel; James N George; Robert McMillan; Diane Kholos Wysocki; Janet L Nichol
Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective.
Health and quality of life outcomes 2008;6():13.
2008: Zeeshan Butt; Lynne I Wagner; Jennifer L Beaumont; Judith A Paice; Amy Peterman; Dan Shevrin; Jamie H Von Roenn; George Carro; Joshua Straus; J. Cameron Muir; David Cella
Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice.
Journal of pain and symptom management 2008;35(1):20-30.
2008: J Douglas Rizzo; Mark R Somerfield; Karen L Hagerty; Jerome Seidenfeld; Julia Bohlius; Charles L Bennett; David Cella; Benjamin Djulbegovic; Matthew J Goode; Ann Jakubowski; Mark U Rarick; David H Regan; Alan E Lichtin
Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(1):132-49.
2008: J Douglas Rizzo; Mark R Somerfield; Karen L Hagerty; Jerome Seidenfeld; Julia Bohlius; Charles L Bennett; David Cella; Benjamin Djulbegovic; Matthew J Goode; Ann Jakubowski; Mark U Rarick; David H Regan; Alan E Lichtin
Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update.
Blood 2008;111(1):25-41.
2008: David Cella; Lesley Fallowfield
Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy.
Breast cancer research and treatment 2008;107(2):167-80.
2008: Lynne I Wagner; Jennifer L Beaumont; Beiying Ding; Jennifer Malin; Amy Peterman; Elizabeth A Calhoun; David Cella
Measuring health-related quality of life and neutropenia-specific concerns among older adults undergoing chemotherapy: validation of the Functional Assessment of Cancer Therapy-Neutropenia (FACT-N).
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2008;16(1):47-56.
2007: Kathy D Miller; Molin Wang; Julie R Gralow; Maura Dickler; Melody A Cobleigh; Edith A Perez; Tamara N Shenkier; David Cella; Nancy E Davidson
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.
The New England journal of medicine 2007;357(26):2666-76.
2007: Lori Perez; Jennifer Huang; Liz Jansky; Cindy Nowinski; David Victorson; Amy Peterman; David Cella
Using focus groups to inform the Neuro-QOL measurement tool: exploring patient-centered, health-related quality of life concepts across neurological conditions.
The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses 2007;39(6):342-53.
2007: Charles F von Gunten; Sarah Eappen; James Francis Cleary; Samuel G Taylor; Paul Moots; Nina Regevik; Charles S Cleeland; David Cella
Flecainide for the treatment of chronic neuropathic pain: a Phase II trial.
Palliative medicine 2007;21(8):667-72.
2007: Susan Yount; Marcy A List; Hongyan Du; Kathleen J Yost; Rita Bode; Bruce E Brockstein; Athanassios Argiris; Everett E Vokes; Ezra E W Cohen; Bruce Campbell; Veronica Valenzuela; Jacquelyn George; Robyn Egan; Jessica Chen; David Meddis; David Cella
A randomized validation study comparing embedded versus extracted FACT Head and Neck Symptom Index scores.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2007;16(10):1615-26.
2007: R Krishnan; David Cella; Craig L Leonardi; Kim A Papp; Alice B Gottlieb; M Dunn; C F Chiou; V Patel; Angelika Jahreis
Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks.
The British journal of dermatology 2007;157(6):1275-7.
2007: Sarah K Rosenbloom; David E Victorson; Elizabeth A Hahn; Amy Peterman; David Cella
Assessment is not enough: a randomized controlled trial of the effects of HRQL assessment on quality of life and satisfaction in oncology clinical practice.
Psycho-oncology 2007;16(12):1069-79.
2007: Gershon Y Locker; Robert Mansel; David Cella; Deborah G Dobrez; Sonja Sorensen; Sanjay K Gandhi
Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen Alone or in Combination) trial.
Breast cancer research and treatment 2007;106(2):229-38.
2007: Sofia F Garcia; David Cella; Steven B Clauser; Kathryn E Flynn; Thomas Lad; Jin-Shei Lai; Bryce B Reeve; Ashley Wilder Smith; Arthur A Stone; Kevin P Weinfurt
Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(32):5106-12.
2007: Lynne I Wagner; Lari Wenzel; Edward Shaw; David Cella
Patient-reported outcomes in phase II cancer clinical trials: lessons learned and future directions.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(32):5058-62.
2007: Deborah Watkins-Bruner; Charlene J Bryan; Neil Aaronson; C Craig Blackmore; Michael Brundage; David Cella; Patricia Anne Ganz; Carolyn C Gotay; Pamela S Hinds; Alice B Kornblith; Benjamin Movsas; Jeff Sloan; Lari Wenzel; Giles Whalen
Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(32):5051-7.
2007: Susan Yount; Mark Sorensen; David Cella; N Sengupta; J Grober; E K Chartash
Adalimumab plus methotrexate or standard therapy is more effective than methotrexate or standard therapies alone in the treatment of fatigue in patients with active, inadequately treated rheumatoid arthritis.
Clinical and experimental rheumatology 2007;25(6):838-46.
2007: CLAIRE SNYDER; Maria E Watson; Joseph D Jackson; David Cella; Michele Y Halyard
Patient-reported outcome instrument selection: designing a measurement strategy.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2007;10 Suppl 2():S76-85.
2007: Elizabeth A Hahn; David Cella; Olivier Chassany; Diane L Fairclough; Gilbert Y Wong; Ron Hays
Precision of health-related quality-of-life data compared with other clinical measures.
Mayo Clinic proceedings. Mayo Clinic 2007;82(10):1244-54.
2007: Parag Agnihotri; Margaret Telfer; Zeeshan Butt; Abhay Jella; David Cella; Chris M Kozma; Mukesh Ahuja; Shahbaz Riaz; Joseph Atiah Akamah
Chronic anemia and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa.
Journal of the American Geriatrics Society 2007;55(10):1557-65.
2007: Kimberly Davis; Susan Yount; Katie Del Ciello; Margaret Whalen; SA Khan; Mike Bass; Hongyan Du; David Eton; Gregory Masters; Thomas A Hensing; David Cella
An innovative symptom monitoring tool for people with advanced lung cancer: a pilot demonstration.
The journal of supportive oncology 2007;5(8):381-7.
2007: A Simon Pickard; Thomas Kohlmann; Mathieu F Janssen; Gouke J Bonsel; Sarah Rosenbloom; David Cella
Evaluating equivalency between response systems: application of the Rasch model to a 3-level and 5-level EQ-5D.
Medical care 2007;45(9):812-9.
2007: David T Eton; David Cella; Susan E Yount; Kimberly M Davis
Validation of the functional assessment of cancer therapy--lung symptom index-12 (FLSI-12).
Lung cancer (Amsterdam, Netherlands) 2007;57(3):339-47.
2007: David Cella; Susan Yount; Penny S Brucker; Hongyan Du; Ronald Bukowski; Nicholas Vogelzang; William P Bro
Development and validation of a scale to measure disease-related symptoms of kidney cancer.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2007;10(4):285-93.
2007: Deborah G Dobrez; David Cella; A Simon Pickard; Jin-Shei Lai; Angel Nickolov
Estimation of patient preference-based utility weights from the functional assessment of cancer therapy - general.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2007;10(4):266-72.
2007: Jin-Shei Lai; David Cella; Mary Jo Kupst; Suzanne Holm; Michael E Kelly; Rita K Bode; Stewart Goldman
Measuring fatigue for children with cancer: development and validation of the pediatric Functional Assessment of Chronic Illness Therapy-Fatigue (pedsFACIT-F).
Journal of pediatric hematology/oncology 2007;29(7):471-9.
2007: David M Gershenson; Anna M Miller; Victoria L Champion; Patrick O Monahan; Qianqian Zhao; David Cella; Stephen D Williams
Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2792-7.
2007: Richard Mularski; Kenneth Rosenfeld; Stephen Joel Coons; Amylou Dueck; David Cella; David J Feuer; Joseph Lipscomb Jr; Martin S Karpeh; Tom Mosich; Jeff A Sloan; Robert S Krouse
Measuring outcomes in randomized prospective trials in palliative care.
Journal of pain and symptom management 2007;34(1 Suppl):S7-S19.
2007: Sarah L Chamlin; Jin-Shei Lai; David Cella; Ilona J Frieden; Mary L Williams; Anthony J Mancini; Mary-Margaret Chren
Childhood Atopic Dermatitis Impact Scale: reliability, discriminative and concurrent validity, and responsiveness.
Archives of dermatology 2007;143(6):768-72.
2007: Ronald Bukowski; David Cella; Kathleen Gondek; Bernard Escudier
Effects of sorafenib on symptoms and quality of life: results from a large randomized placebo-controlled study in renal cancer.
American journal of clinical oncology 2007;30(3):220-7.
2007: Stephanie R Land; Jacek A Kopec; Reena S Cecchini; Patricia Anne Ganz; H Samuel Wieand; Linda H Colangelo; Kate Murphy; J Philip Kuebler; Thomas E Seay; Burton M Needles; James Bearden; Lauren K Colman; Keith S Lanier; Eduardo R Pajon; David Cella; Roy E Smith; Michael J O'Connell; Joseph P Costantino; Norman Wolmark
Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(16):2205-11.
2007: Victoria L Champion; Stephen D Williams; Anna Miller; Kristina M Reuille; Kim Wagler Ziner; Patrick O Monahan; Qianqian Zhao; David M Gershenson; David Cella
Quality of life in long-term survivors of ovarian germ cell tumors: a Gynecologic Oncology Group study.
Gynecologic oncology 2007;105(3):687-94.
2007: Deepa Rao; Elizabeth A Hahn; David Cella; Lesbia Hernandez
The health related quality of life outcomes of English and Spanish speaking persons living with HIV/AIDS from the continental United States and Puerto Rico.
AIDS patient care and STDs 2007;21(5):339-46.
2007: Ron Hays; Honghu Liu; Karen L Spritzer; David Cella
Item response theory analyses of physical functioning items in the medical outcomes study.
Medical care 2007;45(5 Suppl 1):S32-8.
2007: David Cella; Susan Yount; Nan Rothrock; Richard Gershon; Karon Cook; Bryce B Reeve; Deborah Ader; James F Fries; Bonnie Bruce; Mattias Rose
The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years.
Medical care 2007;45(5 Suppl 1):S3-S11.
2007: Bryce B Reeve; Ron Hays; Jakob B Bjorner; Karon F Cook; Paul K Crane; Jeanne A Teresi; David Thissen; Dennis A Revicki; David J Weiss; Ronald K Hambleton; Honghu Liu; Richard Gershon; Steven P Reise; Jin-Shei Lai; David Cella
Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS).
Medical care 2007;45(5 Suppl 1):S22-31.
2007: Joel B Epstein; Jennifer L Beaumont; Clement K Gwede; Barbara Murphy; Adam S Garden; Ruby Meredith; Quynh-Thu Le; David M. Brizel; John Isitt; David Cella
Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire.
Cancer 2007;109(9):1914-22.
2007: Jin-Shei Lai; Mary Jo Kupst; David Cella; Steven R Brown; Amy Peterman; Stewart Goldman
Using Q-methodology to understand perceived fatigue reported by adolescents with cancer.
Psycho-oncology 2007;16(5):437-47.
2007: Michelle M Bishop; Jennifer L Beaumont; Elizabeth A Hahn; David Cella; Michael A Andrykowski; Marianne J Brady; Mary M Horowitz; Kathleen A Sobocinski; J Douglas Rizzo; John R Wingard
Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(11):1403-11.
2007: Elizabeth A Hahn; David Cella; Deborah G Dobrez; Barry D Weiss; Hongyan Du; Jin-Shei Lai; David Victorson; Sofia F Garcia
The impact of literacy on health-related quality of life measurement and outcomes in cancer outpatients.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2007;16(3):495-507.
2007: David Cella
[The concept of quality of life: palliative care and quality of life].
Recherche en soins infirmiers 2007;(88):25-31.
2007: H Q Huang; Mark F Brady; David Cella; G Fleming
Validation and reduction of FACT/GOG-Ntx subscale for platinum/paclitaxel-induced neurologic symptoms: a gynecologic oncology group study.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2007;17(2):387-93.
2007: A Simon Pickard; Maria C De Leon; Thomas Kohlmann; David Cella; Sarah Rosenbloom
Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients.
Medical care 2007;45(3):259-63.
2007: Lari Wenzel; Helen Q Huang; Deborah K Armstrong; Joan L Walker; David Cella
Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: a Gynecologic Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(4):437-43.
2007: Paul K Crane; Laura E Gibbons; Kaavya Narasimhalu; Jin-Shei Lai; David Cella
Rapid detection of differential item functioning in assessments of health-related quality of life: The Functional Assessment of Cancer Therapy.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2007;16(1):101-14.
2007: A Simon Pickard; Maureen P Neary; David Cella
Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer.
Health and quality of life outcomes 2007;5():70.
2007: David Cella; Lynne Wagner; John Cashy; Thomas A Hensing; Susan Yount; Rogerio Lilenbaum
Should health-related quality of life be measured in cancer symptom management clinical trials? Lessons learned using the functional assessment of cancer therapy.
Journal of the National Cancer Institute. Monographs 2007;(37):53-60.
2007: Gale Harding; David Cella; Don Robinson; Parthiv Mahadevia; Jason Clark; Dennis A Revicki
Symptom burden among patients with renal cell carcinoma (RCC): content for a symptom index.
Health and quality of life outcomes 2007;5():34.
2007: Paul K Crane; Laura E Gibbons; Katja Ocepek-Welikson; Karon Cook; David Cella; Kaavya Narasimhalu; Ron Hays; Jeanne A Teresi
A comparison of three sets of criteria for determining the presence of differential item functioning using ordinal logistic regression.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2007;16 Suppl 1():69-84.
2007: Jeanne A Teresi; Katja Ocepek-Welikson; Marjorie Kleinman; Karon F Cook; Paul K Crane; Laura E Gibbons; Leo S Morales; Maria Orlando-Edelen; David Cella
Evaluating measurement equivalence using the item response theory log-likelihood ratio (IRTLR) method to assess differential item functioning (DIF): applications (with illustrations) to measures of physical functioning ability and general distress.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2007;16 Suppl 1():43-68.
2007: David Cella; Richard Gershon; Jin-Shei Lai; Seung Choi
The future of outcomes measurement: item banking, tailored short-forms, and computerized adaptive assessment.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2007;16 Suppl 1():133-41.
2007: Karon F Cook; Cayla R Teal; Jakob B Bjorner; David Cella; Chih-Hung Chang; Paul K Crane; Laura E Gibbons; Ron Hays; Colleen A McHorney; Katja Ocepek-Welikson; Anastasia Raczek; Jeanne A Teresi; Bryce B Reeve
IRT health outcomes data analysis project: an overview and summary.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2007;16 Suppl 1():121-32.
2007: Brad Davidson; Diane Blum; David Cella; Heidi Hamilton; Lillian M Nail; Roger Waltzman
Communicating about chemotherapy-induced anemia.
The journal of supportive oncology 2007;5(1):36-40, 46.
2007: Chih-Hung Chang; Benjamin D Wright; David Cella; Ron Hays
The SF-36 physical and mental health factors were confirmed in cancer and HIV/AIDS patients.
Journal of clinical epidemiology 2007;60(1):68-72.
2007: Jin-Shei Lai; David Cella; Tadanori Tomita; Rita K Bode; Monica Newmark; Stewart Goldman
Developing a health-related quality of life instrument for childhood brain tumor survivors.
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2007;23(1):47-57.
2006: Bernhard Holzner; R K Bode; Elizabeth A Hahn; David Cella; Martin Kopp; Barbara Sperner-Unterweger; Georg Kemmler
Equating EORTC QLQ-C30 and FACT-G scores and its use in oncological research.
European journal of cancer (Oxford, England : 1990) 2006;42(18):3169-77.
2006: David Cella; Lesley Fallowfield; Peter Barker; Jack Cuzick; Gershon Locker; Anthony Howell
Quality of life of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer.
Breast cancer research and treatment 2006;100(3):273-84.
2006: David Cella; Jennifer L Beaumont; Kimberly A Webster; Jin-Shei Lai; Linda S Elting
Measuring the concerns of cancer patients with low platelet counts: the Functional Assessment of Cancer Therapy--thrombocytopenia (FACT-Th) questionnaire.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2006;14(12):1220-31.
2006: Richard T Penson; Lari Wenzel; Ignace Vergote; David Cella
Quality of life considerations in gynecologic cancer. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2006;95 Suppl 1():S247-57.
2006: Peter Hagell; Arja Höglund; Jan Reimer; Brita Eriksson; Ingmari Knutsson; Håkan Widner; David Cella
Measuring fatigue in Parkinson's disease: a psychometric study of two brief generic fatigue questionnaires.
Journal of pain and symptom management 2006;32(5):420-32.
2006: Elizabeth A Hahn; David Cella; Rita K Bode; Richard Gershon; Jin-Shei Lai
Item banks and their potential applications to health status assessment in diverse populations.
Medical care 2006;44(11 Suppl 3):S189-97.
2006: Jeff A Sloan; Marlene H Frost; Rick Berzon; Amylou Dueck; Gordon Guyatt; Carol M Moinpour; Mirjam Sprangers; Carol J Ferrans; David Cella
The clinical significance of quality of life assessments in oncology: a summary for clinicians.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2006;14(10):988-98.
2006: David T Eton; Kathleen J Yost; David Cella
Future trends in patient-reported outcomes assessment for patients with advanced-stage lung cancer receiving targeted therapy.
Clinical lung cancer 2006;8(2):99-109.
2006: Deborah Watkins-Bruner; Susan A. Nolte; M S Shahin; H Q Huang; E Sobel; D Gallup; David Cella
Measurement of vaginal length: Reliability of the vaginal sound--a Gynecologic Oncology Group study.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(5):1749-55.
2006: Jin-Shei Lai; Paul K Crane; David Cella
Factor analysis techniques for assessing sufficient unidimensionality of cancer related fatigue.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2006;15(7):1179-90.
2006: Thomas J Herzog; Robert L Coleman; Maurie Markman; David Cella; J Tate Thigpen
The role of maintenance therapy and novel taxanes in ovarian cancer.
Gynecologic oncology 2006;102(2):218-25.
2006: David Cella
Quality of life and clinical decisions in chemotherapy-induced anemia.
Oncology (Williston Park, N.Y.) 2006;20(8 Suppl 6):25-8.
2006: William J Gradishar; David Cella
Selective estrogen receptor modulators and prevention of invasive breast cancer.
JAMA : the journal of the American Medical Association 2006;295(23):2784-6.
2006: David Cella; Daniel P Petrylak; Mayer Fishman; Chris Teigland; Jay Young; Parvez Mulani
Role of quality of life in men with metastatic hormone-refractory prostate cancer: how does atrasentan influence quality of life?
European urology 2006;49(5):781-9.
2006: Richard P McQuellon; Howard T Thaler; David Cella; David H Moore
Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study.
Gynecologic oncology 2006;101(2):296-304.
2006: David Cella
The FDA and the person with cancer: give PROs a chance.
Oncology (Williston Park, N.Y.) 2006;20(4):436.
2006: David Cella; Susan Yount; Hongyan Du; Rahul Dhanda; Kathleen Gondek; Katie Langefeld; Jacquelyn George; William P Bro; Celeste Kelly; Ronald Bukowski
Development and validation of the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI).
The journal of supportive oncology 2006;4(4):191-9.
2006: Trudy Mallinson; David Cella; John Cashy; Bernhard Holzner
Giving meaning to measure: linking self-reported fatigue and function to performance of everyday activities.
Journal of pain and symptom management 2006;31(3):229-41.
2006: Joel D Kallich; Anne McDermott; X Xu; Peter M Fayers; David Cella
The relationship between patient knowledge of hemoglobin levels and health-related quality of life.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2006;15(1):57-68.
2006: Jennifer L Steel; D T Eton; David Cella; Marion C Olek; Brian I Carr
Clinically meaningful changes in health-related quality of life in patients diagnosed with hepatobiliary carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(2):304-12.
2006: David Victorson; Mehul Soni; David Cella
Metaanalysis of the correlation between radiographic tumor response and patient-reported outcomes.
Cancer 2006;106(3):494-504.
2006: Stephen Tyring; Alice Gottlieb; Kim A Papp; Ken Gordon; Craig L Leonardi; Andrea Wang; Deepa Lalla; Michael Woolley; Angelika Jahreis; Ralph Zitnik; David Cella; Ranga Krishnan
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.
Lancet 2006;367(9504):29-35.
2006: Dennis A Revicki; David Cella; Ron Hays; Jeff A Sloan; William R Lenderking; Neil K Aaronson
Responsiveness and minimal important differences for patient reported outcomes.
Health and quality of life outcomes 2006;4():70.
2006: David T Eton; David Cella; Jennifer Bacik; Robert J Motzer
A brief symptom index for advanced renal cell carcinoma.
Health and quality of life outcomes 2006;4():68.
2006: Elizabeth A Hahn; Rita K Bode; Hongyan Du; David Cella
Evaluating linguistic equivalence of patient-reported outcomes in a cancer clinical trial.
Clinical trials (London, England) 2006;3(3):280-90.
2006: Emuella Flood; Kathleen M Beusterien; Hannah Green; Richard Shikiar; Robert W Baran; Mayur M Amonkar; David Cella
Psychometric evaluation of the Osteoporosis Patient Treatment Satisfaction Questionnaire (OPSAT-Q), a novel measure to assess satisfaction with bisphosphonate treatment in postmenopausal women.
Health and quality of life outcomes 2006;4():42.
2006: A Simon Pickard; Deborah G Dobrez; David Cella
Eliciting social preference weights for functional assessment of cancer therapy-lung health states.
PharmacoEconomics 2006;24(3):293-4; author reply 294-6.
2006: Rita K Bode; Jin-Shei Lai; Kelly Dineen; Allen W Heinemann; Daniel Shevrin; Jamie H Von Roenn; David Cella
Expansion of a physical function item bank and development of an abbreviated form for clinical research.
Journal of applied measurement 2006;7(1):1-15.
2005: Sarah L Chamlin; David Cella; Ilona J Frieden; Mary L Williams; Anthony J Mancini; Jin-Shei Lai; Mary-Margaret Chren
Development of the Childhood Atopic Dermatitis Impact Scale: initial validation of a quality-of-life measure for young children with atopic dermatitis and their families.
The Journal of investigative dermatology 2005;125(6):1106-11.
2005: Kathleen J Yost; David Cella; A Chawla; E Holmgren; David T Eton; John Z Ayanian; D W West
Minimally important differences were estimated for the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) instrument using a combination of distribution- and anchor-based approaches.
Journal of clinical epidemiology 2005;58(12):1241-51.
2005: Jeff A Sloan; David Cella; Ron Hays
Clinical significance of patient-reported questionnaire data: another step toward consensus.
Journal of clinical epidemiology 2005;58(12):1217-9.
2005: George M Rodgers; David Cella; Asher Chanan-Khan; Carolyn Chesney; Charles S Cleeland; Peter F. Coccia; George D Demetri; Benjamin Djulbegovic; Jennifer Garst; Margaret Gore; Eric H Kraut; Weei-Chin Lin; Michael Millenson; Victoria Mock; Denise Reinke; Joseph Rosenthal; Paul Sabbatini
Cancer- and treatment-related anemia.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(6):772-89.
2005: Jin-Shei Lai; David Cella; Amy Peterman; Joshua Barocas; Stewart Goldman
Anorexia/cachexia-related quality of life for children with cancer.
Cancer 2005;104(7):1531-9.
2005: James F Fries; B Bruce; David Cella
The promise of PROMIS: using item response theory to improve assessment of patient-reported outcomes.
Clinical and experimental rheumatology 2005;23(5 Suppl 39):S53-7.
2005: Jin-Shei Lai; Kelly Dineen; Bryce B Reeve; Jamie H Von Roenn; Daniel Shervin; Michael McGuire; Rita K Bode; Judith Paice; David Cella
An item response theory-based pain item bank can enhance measurement precision.
Journal of pain and symptom management 2005;30(3):278-88.
2005: Lari Wenzel; Helen Q Huang; Bradley J Monk; Peter G Rose; David Cella
Quality-of-life comparisons in a randomized trial of interval secondary cytoreduction in advanced ovarian carcinoma: a Gynecologic Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5605-12.
2005: Sarah L Chamlin; Christine L Mattson; Ilona J Frieden; Mary L Williams; Anthony J Mancini; David Cella; Mary-Margaret Chren
The price of pruritus: sleep disturbance and cosleeping in atopic dermatitis.
Archives of pediatrics & adolescent medicine 2005;159(8):745-50.
2005: Bradley J Monk; Helen Q Huang; David Cella; Harry J Long
Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(21):4617-25.
2005: Richard T Penson; David Cella; Lari Wenzel
Quality of life in ovarian cancer.
The Journal of reproductive medicine 2005;50(6):407-16.
2005: Elizabeth A Hahn; Bernhard Holzner; Georg Kemmler; Barbara Sperner-Unterweger; Stacie A Hudgens; David Cella
Cross-cultural evaluation of health status using item response theory: FACT-B comparisons between Austrian and U.S. patients with breast cancer.
Evaluation & the health professions 2005;28(2):233-59.
2005: Sonya L Eremenco; David Cella; Benjamin J Arnold
A comprehensive method for the translation and cross-cultural validation of health status questionnaires.
Evaluation & the health professions 2005;28(2):212-32.
2005: Penny S Brucker; Kathleen J Yost; John Cashy; Kimberly Webster; David Cella
General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G).
Evaluation & the health professions 2005;28(2):192-211.
2005: David T Eton; Jin-Shei Lai; David Cella; Bryce B Reeve; James A Talcott; Jack A Clark; Carol P McPherson; Mark S Litwin; Carol M Moinpour
Data pooling and analysis to build a preliminary item bank: an example using bowel function in prostate cancer.
Evaluation & the health professions 2005;28(2):142-59.
2005: David Cella; Chih-Hung Chang; Benjamin D Wright; Jamie H Von Roenn; Roland T Skeel
Defining higher order dimensions of self-reported health: further evidence for a two-dimensional structure.
Evaluation & the health professions 2005;28(2):122-41.
2005: David T Eton; Karen Koffler; David Cella; Amy R Eisenstein; John A Astin; Kenneth R Pelletier; David Riley
Developing a self-report outcome measure for complementary and alternative medicine.
Explore (New York, N.Y.) 2005;1(3):177-85.
2005: David Cella; Susan Yount; Mark Sorensen; Elliot Chartash; Nishan Sengupta; James Grober
Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis.
The Journal of rheumatology 2005;32(5):811-9.
2005: Monika Janda; Andreas Obermair; David Cella; Lewis C Perrin; James L Nicklin; Bruce G Ward; Alex J Crandon; Michael Trimmel
The functional assessment of cancer-vulvar: reliability and validity.
Gynecologic oncology 2005;97(2):568-75.
2005: David Cella; Roy S Herbst; Thomas J Lynch; Diane Prager; Chandra P Belani; Joan H Schiller; Anne Heyes; Judith S Ochs; Michael K Wolf; Andrea C Kay; Mark G Kris; Ronald B Natale
Clinically meaningful improvement in symptoms and quality of life for patients with non-small-cell lung cancer receiving gefitinib in a randomized controlled trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(13):2946-54.
2005: Zeeshan Butt; Kimberly Webster; Amy R Eisenstein; Jennifer Beaumont; David Eton; Gregory A Masters; David Cella
Quality of life in lung cancer: the validity and cross-cultural applicability of the Functional Assessment Of Cancer Therapy-Lung scale.
Hematology/oncology clinics of North America 2005;19(2):389-420, viii.
2005: Kathleen J Yost; Susan E Yount; David T Eton; Cheryl Silberman; Anne Broughton-Heyes; David Cella
Validation of the Functional Assessment of Cancer Therapy-Breast Symptom Index (FBSI).
Breast cancer research and treatment 2005;90(3):295-8.
2005: Kathleen J Yost; Mark V Sorensen; Elizabeth A Hahn; G Alastair Glendenning; Ari Gnanasakthy; David Cella
Using multiple anchor- and distribution-based estimates to evaluate clinically meaningful change on the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) instrument.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2005;8(2):117-27.
2005: Janice N Cormier; Latunya Davidson; Yan Xing; Kimberly Webster; David Cella
Measuring quality of life in patients with melanoma: development of the FACT-melanoma subscale.
The journal of supportive oncology 2005;3(2):139-45.
2005: David Cella
Quality of life outcomes: measurement and intervention.
The journal of supportive oncology 2005;3(2):133-4.
2005: Jin-Shei Lai; David Cella; Kelly Dineen; Rita K Bode; Jamie H Von Roenn; Richard C Gershon; Daniel Shevrin
An item bank was created to improve the measurement of cancer-related fatigue.
Journal of clinical epidemiology 2005;58(2):190-7.
2005: Michael A Andrykowski; Michelle M Bishop; Elizabeth A Hahn; David Cella; Jennifer L Beaumont; Marianne J Brady; Mary M Horowitz; Kathleen A Sobocinski; J Douglas Rizzo; John R Wingard
Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):599-608.
2005: Lari Wenzel; Aysun Dogan-Ates; Rana Habbal; Ross Berkowitz; Donald P Goldstein; Marilyn Bernstein; Brenda Kluhsman; Kathryn Osann; Edward Newlands; Michael J Seckl; Barry Hancock; David Cella
Defining and measuring reproductive concerns of female cancer survivors.
Journal of the National Cancer Institute. Monographs 2005;(34):94-8.
2005: James Illman; Robert Corringham; Don Robinson; Hugh M Davis; Jean-Francois Rossi; David Cella; Mohit Trikha
Are inflammatory cytokines the common link between cancer-associated cachexia and depression?
The journal of supportive oncology 2005;3(1):37-50.
2004: David Cella
Quality of life considerations in patients with advanced lung cancer.
Seminars in oncology 2004;31(6 Suppl 11):16-20.
2004: Lesley Fallowfield; David Cella; Jack Cuzick; Stephen Francis; Gershon Locker; Anthony Howell
Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(21):4261-71.
2004: Stephanie J Lee; Steven Joffe; Haesook T Kim; Gerard Socie; Andrew Gilman; John R Wingard; Mary M Horowitz; David Cella; Karen L Syrjala
Physicians' attitudes about quality-of-life issues in hematopoietic stem cell transplantation.
Blood 2004;104(7):2194-200.
2004: David T Eton; David Cella; Kathleen J Yost; Susan E Yount; Amy Peterman; Donna S Neuberg; George W Sledge; William C Wood
A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale.
Journal of clinical epidemiology 2004;57(9):898-910.
2004: Monika Janda; Andreas Obermair; David Cella; Alex J Crandon; Michael Trimmel
Vulvar cancer patients' quality of life: a qualitative assessment.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2004;14(5):875-81.
2004: Lynne I Wagner; David Cella
Fatigue and cancer: causes, prevalence and treatment approaches.
British journal of cancer 2004;91(5):822-8.
2004: Kimberly Davis; Susan Yount; Lynne Wagner; David Cella
Measurement and management of health-related quality of life in lung cancer.
Clinical advances in hematology & oncology : H&O 2004;2(8):533-40.
2004: Chanita Hughes Halbert; Marc D Schwartz; Lari Wenzel; Steven A Narod; Beth N Peshkin; David Cella; Caryn Lerman
Predictors of cognitive appraisals following genetic testing for BRCA1 and BRCA2 mutations.
Journal of behavioral medicine 2004;27(4):373-92.
2004: David H Moore; John A Blessing; Richard P McQuellon; Howard T Thaler; David Cella; Jo Ann Benda; David S Miller; George Olt; Stephanie King; John F Boggess; Thomas F Rocereto
Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(15):3113-9.
2004: David Cella
The Functional Assessment of Cancer Therapy-Lung and Lung Cancer Subscale assess quality of life and meaningful symptom improvement in lung cancer.
Seminars in oncology 2004;31(3 Suppl 9):11-5.
2004: Gini F Fleming; Virginia L Brunetto; David Cella; Katherine Y Look; Gary C Reid; Adnan R Munkarah; Richard Kline; Robert A Burger; Annekathryn Goodman; R Tucker Burks
Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(11):2159-66.
2004: David Cella; Joel D Kallich; Anne McDermott; X Xu
The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trials.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(6):979-86.
2004: Jennifer Bacik; Madhu Mazumdar; Barbara A Murphy; D L Fairclough; S Eremenco; Tania V Mariani; Robert J Motzer; David Cella
The functional assessment of cancer therapy-BRM (FACT-BRM): a new tool for the assessment of quality of life in patients treated with biologic response modifiers.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2004;13(1):137-54.
2004: Elizabeth A Hahn; David Cella; Deborah G Dobrez; Gail Shiomoto; Elizabeth Marcus; Samuel G Taylor; Mala Vohra; Chih-Hung Chang; Benjamin D Wright; John M Linacre; Barry D Weiss; Veronica Valenzuela; Hsaio-Lin Chiang; Kimberly Webster
The talking touchscreen: a new approach to outcomes assessment in low literacy.
Psycho-oncology 2004;13(2):86-95.
2004: Bernhard Holzner; Georg Kemmler; David Cella; Christina De Paoli; Verena Meraner; Martin Kopp; richard greil; W Wolfgang Fleischhacker; Barbara Sperner-Unterweger
Normative data for functional assessment of cancer therapy--general scale and its use for the interpretation of quality of life scores in cancer survivors.
Acta oncologica (Stockholm, Sweden) 2004;43(2):153-60.
2003: Richard Gershon; David Cella; Kelly Dineen; Sarah Rosenbloom; Amy Peterman; Jin-Shei Lai
Item response theory and health-related quality of life in cancer.
Expert review of pharmacoeconomics & outcomes research 2003;3(6):783-91.
2003: David H Moore; James Donnelly; William P McGuire; Lois Almadrones; David Cella; Thomas J Herzog; Steven E Waggoner
Limited access trial using amifostine for protection against cisplatin- and three-hour paclitaxel-induced neurotoxicity: a phase II study of the Gynecologic Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(22):4207-13.
2003: Elizabeth A Calhoun; Emily E Welshman; C-H Chang; John R Lurain; D A Fishman; T L Hunt; David Cella
Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2003;13(6):741-8.
2003: Mark G Kris; Ronald B Natale; Roy S Herbst; Thomas J Lynch; Diane Prager; Chandra P Belani; Joan H Schiller; Karen Kelly; Harris Spiridonidis; Alan B Sandler; Kathy S Albain; David Cella; Michael K Wolf; Steven D Averbuch; Judith J Ochs; Andrea C Kay
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.
JAMA : the journal of the American Medical Association 2003;290(16):2149-58.
2003: Lari Wenzel; I Vergote; David Cella
Quality of life in patients receiving treatment for gynecologic malignancies: special considerations for patient care.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2003;83 Suppl 1():211-29.
2003: Penny S Brucker; David Cella
Measuring self-reported sexual function in men with prostate cancer.
Urology 2003;62(4):596-606.
2003: Nadine Tchen; Philippe L Bedard; Qi-Long Yi; M Klein; David Cella; S Eremenco; Ian F Tannock
Quality of life and understanding of disease status among cancer patients of different ethnic origin.
British journal of cancer 2003;89(4):641-7.
2003: David Cella
What do global quality-of-life questions really measure? Insights from Hobday et al and the "do something" rule.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(16):3178-9; author reply 3179.
2003: David Cella; Amy Peterman; Stacie A Hudgens; Kimberly Webster; Mark A Socinski
Measuring the side effects of taxane therapy in oncology: the functional assesment of cancer therapy-taxane (FACT-taxane).
Cancer 2003;98(4):822-31.
2003: Jin-Shei Lai; David Cella; Chih-Hung Chang; Rita K Bode; Allen W Heinemann
Item banking to improve, shorten and computerize self-reported fatigue: an illustration of steps to create a core item bank from the FACIT-Fatigue Scale.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2003;12(5):485-501.
2003: David Cella; Janis G Pulliam; Henry Fuchs; Carole B Miller; David D Hurd; John R Wingard; Stephen T Sonis; Paul J Martin; Francis Giles
Evaluation of pain associated with oral mucositis during the acute period after administration of high-dose chemotherapy.
Cancer 2003;98(2):406-12.
2003: Elizabeth A Hahn; G Alastair Glendenning; Mark V Sorensen; Stacie A Hudgens; Brian J Druker; françois guilhot; Richard A Larson; Stephen G O'Brien; Deborah G Dobrez; Martee Hensley; David Cella
Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low-dose cytarabine: results from the IRIS Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(11):2138-46.
2003: David T Eton; Diane L Fairclough; David Cella; Susan E Yount; Philip Bonomi; David H Johnson
Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: results from Eastern Cooperative Oncology Group Study 5592.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(8):1536-43.
2003: Rita K Bode; Jin-Shei Lai; David Cella; Allen W Heinemann
Issues in the development of an item bank.
Archives of physical medicine and rehabilitation 2003;84(4 Suppl 2):S52-60.
2003: Elizabeth A Hahn; David Cella
Health outcomes assessment in vulnerable populations: measurement challenges and recommendations.
Archives of physical medicine and rehabilitation 2003;84(4 Suppl 2):S35-42.
2003: David Cella; Deborah G Dobrez; J Glaspy
Control of cancer-related anemia with erythropoietic agents: a review of evidence for improved quality of life and clinical outcomes.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(4):511-9.
2003: Chih-Hung Chang; David Cella; Susan Clarke; Allen W Heinemann; Jamie H Von Roenn; Richard D. Harvey
Should symptoms be scaled for intensity, frequency, or both?
Palliative & supportive care 2003;1(1):51-60.
2003: C-H Chang; David L Nyenhuis; David Cella; T Luchetta; K Dineen; A T Reder
Psychometric evaluation of the Chicago Multiscale Depression Inventory in multiple sclerosis patients.
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(2):160-70.
2003: Cathy A Coyne; Ronghui Xu; Peter Raich; Kathy Plomer; Mark Dignan; Lari Wenzel; Diane Fairclough; Thomas Habermann; Linda Schnell; Susan K Quella; David Cella
Randomized, controlled trial of an easy-to-read informed consent statement for clinical trial participation: a study of the Eastern Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(5):836-42.
2003: David Cella
Impact of ZD1839 on non-small cell lung cancer-related symptoms as measured by the functional assessment of cancer therapy-lung scale.
Seminars in oncology 2003;30(1 Suppl 1):39-48.
2003: David Cella; Martin J Zagari; Christina Vandoros; Dennis D Gagnon; Hans-Jürgen Hurtz; J W R Nortier
Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(2):366-73.
2003: Mary McGrae McDermott; Philip Greenland; Elizabeth A Hahn; Donna Brogan; David Cella; Judith Ockene; William H Pearce; Michael H Criqui; Alan Hirsch; Martin Lipsky; Linda Odom; Kendra Hanley; SA Khan
The effects of continuing medical education credits on physician response rates to a mailed questionnaire.
Health marketing quarterly 2003;20(4):27-42.
2003: Kimberly Webster; David Cella; Kathleen Yost
The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation.
Health and quality of life outcomes 2003;1():79.
2003: Stacie A Hudgens; David Cella; Carol Ann Caprini; Joseph A Caprini
Deep vein thrombosis: validation of a patient-reported leg symptom index.
Health and quality of life outcomes 2003;1():76.
2003: Susan Yount; David Cella; Donald Banik; Talat Ashraf; Daniel Shevrin
Brief assessment of priority symptoms in hormone refractory prostate cancer: the FACT Advanced Prostate Symptom Index (FAPSI).
Health and quality of life outcomes 2003;1():69.
2003: Jeff A Sloan; David Cella; Marlene H Frost; Gordon Guyatt; David Osoba
Quality of life III: translating the science of quality-of-life assessment into clinical practice-an example-driven approach for practicing clinicians and clinical researchers.
Clinical therapeutics 2003;25 Suppl D():D1-5.
2003: David Cella; Diane Paul; Susan Yount; Rodger Winn; Chih-Hung Chang; Donald Banik; Jane C Weeks
What are the most important symptom targets when treating advanced cancer? A survey of providers in the National Comprehensive Cancer Network (NCCN).
Cancer investigation 2003;21(4):526-35.
2003: Rita K Bode; David Cella; Jin-Shei Lai; Allen W Heinemann
Developing an initial physical function item bank from existing sources.
Journal of applied measurement 2003;4(2):124-36.
2002: Lesley Fallowfield; D Gagnon; M Zagari; David Cella; B Bresnahan; T J Littlewood; P McNulty; G Gorzegno; M Freund
Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy.
British journal of cancer 2002;87(12):1341-53.
2002: David Cella; David T Eton; Jin-Shei Lai; Amy Peterman; Douglas E Merkel
Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales.
Journal of pain and symptom management 2002;24(6):547-61.
2002: Mehul K Soni; David Cella
Quality of life and symptom measures in oncology: an overview.
The American journal of managed care 2002;8(18 Suppl):S560-73.
2002: C H Chang; David Cella; O Fernández; Gloria Luque; P de Castro; C de Andrés; B Casanova; M A Hernández; J M Prieto; V E Fernández; Enrique de Ramón
Quality of life in multiple sclerosis patients in Spain.
Multiple sclerosis (Houndmills, Basingstoke, England) 2002;8(6):527-31.
2002: David Cella; Cindy J Nowinski
Measuring quality of life in chronic illness: the functional assessment of chronic illness therapy measurement system.
Archives of physical medicine and rehabilitation 2002;83(12 Suppl 2):S10-7.
2002: Mary McGrae McDermott; Elizabeth A Hahn; Philip Greenland; David Cella; Judith K Ockene; Donna Brogan; William H Pearce; Alan T Hirsch; Kendra Hanley; Linda Odom; SA Khan; Michael H Criqui; Martin Lipsky; Stacie A Hudgens
Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician survey.
Journal of general internal medicine 2002;17(12):895-904.
2002: Mehul K Soni; David Cella; Gregory A Masters; Steven P Burch; Anne Heyes; Cheryl Silberman
The validity and clinical utility of symptom monitoring in advanced lung cancer: a literature review.
Clinical lung cancer 2002;4(3):153-60.
2002: Steven D Passik; Kenneth L Kirsh; Kathleen Donaghy; Elizabeth Holtsclaw; Dale E Theobald; David Cella; William Breitbart
Patient-related barriers to fatigue communication: initial validation of the fatigue management barriers questionnaire.
Journal of pain and symptom management 2002;24(5):481-93.
2002: David Cella
What's in a title? Do Sprangers et al. really explain quality of life with crisis theory?
Psycho-oncology 2002;11(6):540; author reply 541.
2002: David Cella; Chanita Hughes; Amy Peterman; Chih-Hung Chang; Beth N Peshkin; Marc D Schwartz; Lari Wenzel; Amy Lemke; Alfred C Marcus; Caryn Lerman
A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.
Health psychology : official journal of the Division of Health Psychology, American Psychological Association 2002;21(6):564-72.
2002: J Douglas Rizzo; Alan E Lichtin; Steven H Woolf; Jerome Seidenfeld; Charles L Bennett; David Cella; Benjamin Djulbegovic; Matthew J Goode; Ann Jakubowski; Su-Jun Lee; Carole B Miller; Mark U Rarick; David H Regan; George P Browman; Michael S Gordon
Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(19):4083-107.
2002: J Douglas Rizzo; Alan E Lichtin; Steven H Woolf; Jerome Seidenfeld; Charles L Bennett; David Cella; Benjamin Djulbegovic; Matthew J Goode; Ann Jakubowski; Su-Jun Lee; Carole B Miller; Mark U Rarick; David H Regan; George P Browman; Michael S Gordon
Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology.
Blood 2002;100(7):2303-20.
2002: Chih-Hung Chang; David Cella; Gregory A Masters; Nicole Laliberte; Paul E. O'Brien; Amy Peterman; Daniel Shervin
Real-time clinical application of quality-of-life assessment in advanced lung cancer.
Clinical lung cancer 2002;4(2):104-9.
2002: Paul B Jacobsen; Kimberly Davis; David Cella
Assessing quality of life in research and clinical practice.
Oncology (Williston Park, N.Y.) 2002;16(9 Suppl 10):133-9.
2002: David Cella
The effects of anemia and anemia treatment on the quality of life of people with cancer.
Oncology (Williston Park, N.Y.) 2002;16(9 Suppl 10):125-32.
2002: Jeffrey Crawford; David Cella; Charles S Cleeland; Pierre-Yves Cremieux; George D Demetri; Brenda J Sarokhan; Mitchell B Slavin; John A Glaspy
Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy.
Cancer 2002;95(4):888-95.
2002: Timothy J Littlewood; David Cella; J W R Nortier
Erythropoietin improves quality of life.
The lancet oncology 2002;3(8):459-60.
2002: Susan Yount; David Cella; Kimberly Webster; Nancy Heffernan; Chih Chang; Linda Odom; Renilt van Gool
Assessment of patient-reported clinical outcome in pancreatic and other hepatobiliary cancers: the FACT Hepatobiliary Symptom Index.
Journal of pain and symptom management 2002;24(1):32-44.
2002: David Cella; Chih-Hung Chang; Jin-Shei Lai; Kimberly Webster
Advances in quality of life measurements in oncology patients.
Seminars in oncology 2002;29(3 Suppl 8):60-8.
2002: Matti S Aapro; David Cella; Martin Zagari
Age, anemia, and fatigue.
Seminars in oncology 2002;29(3 Suppl 8):55-9.
2002: Scott Wadler; Carlos Brain; Paul J Catalano; Avi I Einzig; David Cella; Al B Benson
Randomized phase II trial of either fluorouracil, parenteral hydroxyurea, interferon-alpha-2a, and filgrastim or doxorubicin/docetaxel in patients with advanced gastric cancer with quality-of-life assessment: eastern cooperative oncology group study E6296.
Cancer journal (Sudbury, Mass.) 2002;8(3):282-6.
2002: David Cella; Elizabeth A Hahn; Kelly Dineen
Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2002;11(3):207-21.
2002: Nancy Heffernan; David Cella; Kimberly Webster; Linda Odom; Mary Martone; Steven D Passik; Marilyn Bookbinder; Yuman Fong; William R Jarnagin; Leslie H Blumgart
Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(9):2229-39.
2002: Susan Yount; Jin-Shei Lai; David Cella
Methods and progress in assessing the quality of life effects of supportive care with erythropoietin therapy.
Current opinion in hematology 2002;9(3):234-40.
2002: David Cella; Monika Bullinger; Charles Scott; Ivan Barofsky
Group vs individual approaches to understanding the clinical significance of differences or changes in quality of life.
Mayo Clinic proceedings. Mayo Clinic 2002;77(4):384-92.
2002: Jeff A Sloan; David Cella; Marlene Frost; Gordon H Guyatt; Mirjam Sprangers; Tara Symonds
Assessing clinical significance in measuring oncology patient quality of life: introduction to the symposium, content overview, and definition of terms.
Mayo Clinic proceedings. Mayo Clinic 2002;77(4):367-70.
2002: Lari Wenzel; James P Donnelly; Jeffery M Fowler; Rana Habbal; Thomas H Taylor; Noreen Aziz; David Cella
Resilience, reflection, and residual stress in ovarian cancer survivorship: a gynecologic oncology group study.
Psycho-oncology 2002;11(2):142-53.
2002: David Cella; David T Eton; Diane L Fairclough; Philip Bonomi; Anne Heyes; Cheryl Silberman; Michael K Wolf; David H Johnson
What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592.
Journal of clinical epidemiology 2002;55(3):285-95.
2002: Corey J Langer; Judith Manola; Patricia Bernardo; John W Kugler; Philip Bonomi; David Cella; David H Johnson
Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial.
Journal of the National Cancer Institute 2002;94(3):173-81.
2002: David Cella; Jin-Shei Lai; Chih-Hung Chang; Amy Peterman; Mitchell Slavin
Fatigue in cancer patients compared with fatigue in the general United States population.
Cancer 2002;94(2):528-38.
2002: Amy Peterman; George Fitchett; Marianne J Brady; Lesbia Hernandez; David Cella
Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy--Spiritual Well-being Scale (FACIT-Sp).
Annals of behavioral medicine : a publication of the Society of Behavioral Medicine 2002;24(1):49-58.
2001: NK Arora; David H Gustafson; Robert P Hawkins; Fiona McTavish; David Cella; Suzanne Pingree; JH Mendenhall; D M Mahvi
Impact of surgery and chemotherapy on the quality of life of younger women with breast carcinoma: a prospective study.
Cancer 2001;92(5):1288-98.
2001: R M Auchter; D Scholtens; S Adak; H Wagner; David Cella; Minesh Mehta
Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Eastern Cooperative Oncology Group.
International journal of radiation oncology, biology, physics 2001;50(5):1199-206.
2001: David Cella; K Davis; William Breitbart; Gregory A Curt
Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(14):3385-91.
2001: David H Gustafson; Robert Hawkins; Suzanne Pingree; Fiona McTavish; NK Arora; JH Mendenhall; David Cella; Ronald C Serlin; F M Apantaku; James A Stewart; Andrew Salner
Effect of computer support on younger women with breast cancer.
Journal of general internal medicine 2001;16(7):435-45.
2001: J H Schiller; S Adak; David Cella; R F DeVore; D H Johnson
Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593--a phase III trial of the Eastern Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2114-22.
2001: Karen Basen-Engquist; DC Bodurka-Bevers; Mary A Fitzgerald; K Webster; David Cella; S Hu; David M Gershenson
Reliability and validity of the functional assessment of cancer therapy-ovarian.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(6):1809-17.
2001: Julian C Schink; E Weller; Linda S Harris; David Cella; J Gerstner; C Falkson; Scott Wadler
Outpatient taxol and carboplatin chemotherapy for suboptimally debulked epithelial carcinoma of the ovary results in improved quality of life: an Eastern Cooperative Oncology Group Phase II Study (E2E93).
Cancer journal (Sudbury, Mass.) 2001;7(2):155-64.
2001: Amy Peterman; David Cella; G Glandon; Deborah G Dobrez; Susan Yount
Mucositis in head and neck cancer: economic and quality-of-life outcomes.
Journal of the National Cancer Institute. Monographs 2001;(29):45-51.
2001: Christine Cameron; David Cella; J E Herndon; Alice B Kornblith; E Zuckerman; E Henderson; Raymond B Weiss; M Robert Cooper; R T Silver; L Leone; George P Canellos; Bruce A Peterson; Jimmie C Holland
Persistent symptoms among survivors of Hodgkin's disease: an explanatory model based on classical conditioning.
Health psychology : official journal of the Division of Health Psychology, American Psychological Association 2001;20(1):71-5.
2000: Victoria Mock; A Atkinson; Andrea M Barsevick; David Cella; Bernadine Cimprich; Charles S Cleeland; J Donnelly; Mario A Eisenberger; C Escalante; P Hinds; Paul B Jacobsen; P Kaldor; Sara J Knight; A Peterman; Barbara F Piper; Hope S Rugo; Paul Sabbatini; C Stahl
NCCN Practice Guidelines for Cancer-Related Fatigue.
Oncology (Williston Park, N.Y.) 2000;14(11A):151-61.
2000: David Cella; C H Chang
A discussion of item response theory and its applications in health status assessment.
Medical care 2000;38(9 Suppl):II66-72.
2000: Robert J Motzer; Barbara A Murphy; Jennifer Bacik; Lawrence H Schwartz; David M Nanus; Tania V Mariani; Patrick J Loehrer; George Wilding; D L Fairclough; David Cella; Madhu Mazumdar
Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(16):2972-80.
2000: L Hernández; C H Chang; David Cella; M Corona; Gail Shiomoto; D B McGuire
Development and validation of the satisfaction with pharmacist scale.
Pharmacotherapy 2000;20(7):837-43.
2000: V Mullin; David Cella; C H Chang; S Eremenco; M Mertz; L Lent; Carla Isadora Falkson; G Falkson
Development of three African language translations of the FACT-G.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2000;9(2):139-49.
2000: P Bonomi; K Kim; D Fairclough; David Cella; J Kugler; eric rowinsky; M Jiroutek; D Johnson
Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(3):623-31.
2000: J M Ribaudo; David Cella; Elizabeth A Hahn; S R Lloyd; N S Tchekmedyian; Jamie H Von Roenn; W T Leslie
Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2000;9(10):1137-46.
2000: G Kiebert; S Wait; J Bernhard; A Bezjak; David Cella; R Day; J Houghton; C Moinpour; C Scott; R Stephens
Practice and policy of measuring quality of life and health economics in cancer clinical trials: a survey among co-operative trial groups.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2000;9(10):1073-80.
2000: Gregory A Curt; William Breitbart; David Cella; JE Groopman; S J Horning; LM Itri; D H Johnson; C Miaskowski; S L Scherr; Russell Portenoy; N J Vogelzang
Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition.
The oncologist 2000;5(5):353-60.
1999: D L Fairclough; John H Fetting; David Cella; W Wonson; C M Moinpour
Quality of life and quality adjusted survival for breast cancer patients receiving adjuvant therapy. Eastern Cooperative Oncology Group (ECOG).
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1999;8(8):723-31.
1999: Lari Wenzel; Diane Fairclough; M J Brady; David Cella; K M Garrett; Brenda Kluhsman; Lori A Crane; Alfred C Marcus
Age-related differences in the quality of life of breast carcinoma patients after treatment.
Cancer 1999;86(9):1768-74.
1999: David Cella; K A Webster
Quality of life and treatment value in the management of hematologic malignancies.
Seminars in oncology 1999;26(5 Suppl 14):34-42.
1999: M J Brady; Amy Peterman; George Fitchett; M Mo; David Cella
A case for including spirituality in quality of life measurement in oncology.
Psycho-oncology 1999;8(5):417-28.
1999: G J Wan; MA Counte; David Cella; L Hernandez; S Deasy; Gail Shiomoto
An analysis of the impact of demographic, clinical, and social factors on health-related quality of life.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 1999;2(4):308-18.
1999: David Cella; D Bron
The effect of Epoetin alfa on quality of life in anemic cancer patients.
Cancer practice 1999;7(4):177-82.
1999: Lesley Fallowfield; S K Leaity; A Howell; S Benson; David Cella
Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B.
Breast cancer research and treatment 1999;55(2):189-99.
1999: W L Ward; Elizabeth A Hahn; F Mo; L Hernandez; D S Tulsky; David Cella
Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1999;8(3):181-95.
1999: Janet Audrain; Barbara K Rimer; David Cella; M Stefanek; Judy E Garber; Marie Pennanen; K Helzlsouer; V Vogel; TH Lin; Caryn Lerman
The impact of a brief coping skills intervention on adherence to breast self-examination among first-degree relatives of newly diagnosed breast cancer patients.
Psycho-oncology 1999;8(3):220-9.
1999: Atsuko Hinotsu; M Niimi; Hideyuki Akaza; Naoto Miyanaga; Hitoshi Takeshima; S Eremenco; David Cella
[Development of Japanese version of QOL questionnaire for bladder and prostate cancer patients using FACT-Bl and P: pilot study].
Gan to kagaku ryoho. Cancer & chemotherapy 1999;26(5):657-66.
1999: M J Brady; David Cella
Assessing quality of life in palliative care.
Cancer treatment and research 1999;100():203-16.
1999: L Lent; E Hahn; S Eremenco; K Webster; David Cella
Using cross-cultural input to adapt the Functional Assessment of Chronic Illness Therapy (FACIT) scales.
Acta oncologica (Stockholm, Sweden) 1999;38(6):695-702.
1999: G J Wan; MA Counte; David Cella; L Hernandez; D B McGuire; S Deasay; Gail Shiomoto; Elizabeth A Hahn
The impact of socio-cultural and clinical factors on health-related quality of life reports among Hispanic and African-American cancer patients.
Journal of outcome measurement 1999;3(3):200-15.
1998: David Cella; Amy Peterman; Steven D Passik; Paul B Jacobsen; William Breitbart
Progress toward guidelines for the management of fatigue.
Oncology (Williston Park, N.Y.) 1998;12(11A):369-77.
1998: Alfred C Marcus; K M Garrett; David Cella; Lari Wenzel; M J Brady; L A Crane; M W McClatchey; Brenda Kluhsman; M Pate-Willig
Telephone counseling of breast cancer patients after treatment: a description of a randomized clinical trial.
Psycho-oncology 1998;7(6):470-82.
1998: George D Demetri; Mark G Kris; James L Wade Iii; L Degos; David Cella
Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3412-25.
1998: David Cella; L Hernandez; AE Bonomi; M Corona; M Vaquero; Gail Shiomoto; L Baez
Spanish language translation and initial validation of the functional assessment of cancer therapy quality-of-life instrument.
Medical care 1998;36(9):1407-18.
1998: John H Fetting; R Gray; D L Fairclough; T J Smith; K A Margolin; M L Citron; M Grove-Conrad; David Cella; Kishan J Pandya; N Robert; I Craig Henderson; C Kent Osborne; MD Abeloff
Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor-negative breast cancer: an Intergroup study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(7):2382-91.
1998: David Cella
Factors influencing quality of life in cancer patients: anemia and fatigue.
Seminars in oncology 1998;25(3 Suppl 7):43-6.
1998: K Webster; David Cella
Quality of life in patients with low-grade non-Hodgkin's lymphoma.
Oncology (Williston Park, N.Y.) 1998;12(5):697-714; discussion 714, 717, 721.
1998: D L Fairclough; H F Peterson; David Cella; P Bonomi
Comparison of several model-based methods for analysing incomplete quality of life data in cancer clinical trials.
Statistics in medicine 1998;17(5-7):781-96.
1998: Elizabeth A Hahn; K A Webster; David Cella; Diane L Fairclough
Missing data in quality of life research in Eastern Cooperative Oncology Group (ECOG) clinical trials: problems and solutions.
Statistics in medicine 1998;17(5-7):547-59.
1998: Jürg Bernhard; David Cella; Alan Coates; L Fallowfield; Patricia Anne Ganz; C M Moinpour; P Mosconi; David Osoba; R John Simes; Christoph Hürny
Missing quality of life data in cancer clinical trials: serious problems and challenges.
Statistics in medicine 1998;17(5-7):517-32.
1998: L Hernández; David Cella
[Health-related quality of life: important result of cancer treatments].
Puerto Rico health sciences journal 1998;17(1):89-91.
1998: Alice B Kornblith; James E Herndon; Enid Zuckerman; David Cella; E Cherin; S Wolchok; Raymond B Weiss; L F Diehl; E Henderson; M Robert Cooper; Charles Alan Schiffer; George P Canellos; Robert J Mayer; R T Silver; A Schilling; Bruce A Peterson; D Greenberg; Jimmie C Holland
Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group B.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(3):297-306.
1998: Marc D Schwartz; Caryn Lerman; Janet Audrain; David Cella; Barbara K Rimer; M Stefanek; Judy E Garber; TH Lin; V Vogel
The impact of a brief problem-solving training intervention for relatives of recently diagnosed breast cancer patients.
Annals of behavioral medicine : a publication of the Society of Behavioral Medicine 1998;20(1):7-12.
1998: Janet Audrain; Barbara K Rimer; David Cella; Judy E Garber; Beth N Peshkin; J Ellis; Joellen M Schildkraut; M Stefanek; V Vogel; Caryn Lerman
Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):133-8.
1997: Peg Esper; F Mo; Gerald Chodak; Michael Sinner; David Cella; Kenneth J Pienta
Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument.
Urology 1997;50(6):920-8.
1997: David Cella; K Webster
Linking outcomes management to quality-of-life measurement.
Oncology (Williston Park, N.Y.) 1997;11(11A):232-5.
1997: Dennis A Revicki; David Cella
Health status assessment for the twenty-first century: item response theory, item banking and computer adaptive testing.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1997;6(6):595-600.
1997: Amy Peterman; David Cella; F Mo; N McCain
Psychometric validation of the revised Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1997;6(6):572-84.
1997: David Cella
The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue.
Seminars in hematology 1997;34(3 Suppl 2):13-9.
1997: N J Vogelzang; William Breitbart; David Cella; Gregory A Curt; JE Groopman; S J Horning; LM Itri; D H Johnson; S L Scherr; Russell Portenoy
Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition.
Seminars in hematology 1997;34(3 Suppl 2):4-12.
1997: G J Wan; MA Counte; David Cella
The influence of personal expectations on cancer patients' reports of health-related quality of life.
Psycho-oncology 1997;6(1):1-11.
1997: Marianne J Brady; David Cella; F Mo; AE Bonomi; D S Tulsky; S R Lloyd; S Deasy; M Cobleigh; Gail Shiomoto
Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):974-86.
1997: S B Yellen; David Cella; K Webster; C Blendowski; E Kaplan
Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system.
Journal of pain and symptom management 1997;13(2):63-74.
1997: Richard P McQuellon; Gregory B Russell; David Cella; Brandon L Craven; M Brady; AE Bonomi; David D Hurd
Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale.
Bone marrow transplantation 1997;19(4):357-68.
1996: David Cella
Quality of life outcomes: measurement and validation.
Oncology (Williston Park, N.Y.) 1996;10(11 Suppl):233-46.
1996: David Cella; Nancy McCain; Amy Peterman; F Mo; Deborah L Wolen
Development and validation of the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1996;5(4):450-63.
1996: David Cella; K Dineen; B Arnason; A Reder; K A Webster; G karabatsos; C Chang; S Lloyd; J Steward; D Stefoski
Validation of the functional assessment of multiple sclerosis quality of life instrument.
Neurology 1996;47(1):129-39.
1996: Nancy McCain; Janice M Zeller; David Cella; P A Urbanski; Richard M Novak
The influence of stress management training in HIV disease.
Nursing research 1996;45(4):246-53.
1996: DL Fairclough; David Cella
Functional Assessment of Cancer Therapy (FACT-G): non-response to individual questions.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1996;5(3):321-9.
1996: A E Bonomi; David Cella; E A Hahn; K Bjordal; B Sperner-Unterweger; L Gangeri; B Bergman; J Willems-Groot; P Hanquet; R Zittoun
Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1996;5(3):309-20.
1996: Marcy A List; Linda L D'Antonio; David Cella; Amy K Siston; P Mumby; Daniel J Haraf; Everett E Vokes
The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity.
Cancer 1996;77(11):2294-301.
1996: S Tross; James Herndon; A Korzun; Alice B Kornblith; David Cella; James F Holland; P Raich; A Johnson; D T Kiang; M Perloff; Larry Norton; W Wood; Jimmie C Holland
Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B.
Journal of the National Cancer Institute 1996;88(10):661-7.
1996: Linda L D'Antonio; Grenith J Zimmerman; David Cella; S A Long
Quality of life and functional status measures in patients with head and neck cancer.
Archives of otolaryngology--head & neck surgery 1996;122(5):482-7.
1996: R Gonin; S Lloyd; David Cella; G Gray
Establishing equivalence between scaled measures of quality of life.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1996;5(1):20-6.
1996: D G Gallup; David Cella
Gynecologic Oncology Group (GOG).
Journal of the National Cancer Institute. Monographs 1996;(20):77-8.
1996: DL Fairclough; David Cella
Eastern Cooperative Oncology Group (ECOG).
Journal of the National Cancer Institute. Monographs 1996;(20):73-5.
1995: David Cella; A E Bonomi
Measuring quality of life: 1995 update.
Oncology (Williston Park, N.Y.) 1995;9(11 Suppl):47-60.
1995: Deborah Watkins-Bruner; C Scott; Colleen A Lawton; John Del Rowe; Marvin Rotman; L Buswell; Clair Beard; David Cella
RTOG's first quality of life study--RTOG 90-20: a phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer.
International journal of radiation oncology, biology, physics 1995;33(4):901-6.
1995: Janet Audrain; Caryn Lerman; Barbara K Rimer; David Cella; R Steffens; A Gomez-Caminero
Awareness of heightened breast cancer risk among first-degree relatives of recently diagnosed breast cancer patients. The High Risk Breast Cancer Consortium.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1995;4(5):561-5.
1995: David Cella; A E Bonomi; S R Lloyd; D S Tulsky; E Kaplan; P Bonomi
Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument.
Lung cancer (Amsterdam, Netherlands) 1995;12(3):199-220.
1995: David Cella; J VonRoenn; S Lloyd; H P Browder
The Bristol-Myers Anorexia/Cachexia Recovery Instrument (BACRI): a brief assessment of patients' subjective response to treatment for anorexia/cachexia.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1995;4(3):221-31.
1995: S B Yellen; David Cella
Someone to live for: social well-being, parenthood status, and decision-making in oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(5):1255-64.
1995: Nancy McCain; David Cella
Correlates of stress in HIV disease.
Western journal of nursing research 1995;17(2):141-55.
1995: David Cella
Measuring quality of life in palliative care.
Seminars in oncology 1995;22(2 Suppl 3):73-81.
1995: Michael A Weitzner; Christina A Meyers; C K Gelke; K S Byrne; David Cella; Victor Levin
The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors.
Cancer 1995;75(5):1151-61.
1995: J F Hermann; David Cella; A Robinovitch
Guidelines for support group programs.
Cancer practice 1995;3(2):111-3.
1995: David Cella
Methods and problems in measuring quality of life.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1995;3(1):11-22.
1994: S B Yellen; David Cella; W T Leslie
Age and clinical decision making in oncology patients.
Journal of the National Cancer Institute 1994;86(23):1766-70.
1994: David Cella
Quality of life: concepts and definition.
Journal of pain and symptom management 1994;9(3):186-92.
1994: David Cella; S R Lloyd
Data collection strategies for patient-reported information.
Quality management in health care 1994;2(4):28-35.
1993: M Bullinger; Roger Anderson; David Cella; N Aaronson
Developing and evaluating cross-cultural instruments from minimum requirements to optimal models.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1993;2(6):451-9.
1993: David Cella; I Wiklund; S A Shumaker; N K Aaronson
Integrating health-related quality of life into cross-national clinical trials.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1993;2(6):433-40.
1993: S B Yellen; David Cella; A Bonomi
Quality of life in people with Hodgkin's disease.
Oncology (Williston Park, N.Y.) 1993;7(8):41-5; discussion 46, 50-2.
1993: David Cella; S B Yellen
Cancer support groups: the state of the art.
Cancer practice 1993;1(1):56-61.
1993: David Cella; D S Tulsky; G Gray; B Sarafian; E Linn; A Bonomi; M Silberman; S B Yellen; P Winicour; J Brannon
The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(3):570-9.
1993: David Cella; D S Tulsky
Quality of life in cancer: definition, purpose, and method of measurement.
Cancer investigation 1993;11(3):327-36.
1992: Douglas Rait; Jamie S Ostroff; K Smith; David Cella; C Tan; L M Lesko
Lives in a balance: perceived family functioning and the psychosocial adjustment of adolescent cancer survivors.
Family process 1992;31(4):383-97.
1992: Alice B Kornblith; J Anderson; David Cella; S Tross; Enid Zuckerman; E Cherin; E S Henderson; George P Canellos; M P Kosty; M Robert Cooper
Comparison of psychosocial adaptation and sexual function of survivors of advanced Hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVD.
Cancer 1992;70(10):2508-16.
1992: David Cella
Overcoming difficulties in demonstrating health outcome benefits.
JPEN. Journal of parenteral and enteral nutrition 1992;16(6 Suppl):106S-111S.
1992: Alice B Kornblith; J Anderson; David Cella; S Tross; Enid Zuckerman; E Cherin; E Henderson; Raymond B Weiss; M Robert Cooper; R T Silver
Hodgkin disease survivors at increased risk for problems in psychosocial adaptation. The Cancer and Leukemia Group B.
Cancer 1992;70(8):2214-24.
1992: David Cella; D S Tulsky; B Sarafian; C R Thomas; C R Thomas
Culturally relevant smoking prevention for minority youth.
The Journal of school health 1992;62(8):377-80.
1992: A J Janov; J Anderson; David Cella; Enid Zuckerman; Alice B Kornblith; Jimmie C Holland; A F Kantor; Frederick P Li; E Henderson; Raymond B Weiss
Pregnancy outcome in survivors of advanced Hodgkin disease.
Cancer 1992;70(3):688-92.
1992: Patricia Anne Ganz; C M Moinpour; David Cella; John H Fetting
Quality-of-life assessment in cancer clinical trials: a status report.
Journal of the National Cancer Institute 1992;84(13):994-5.
1992: S G Nayfield; Patricia Anne Ganz; C M Moinpour; David Cella; B J Hailey
Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1992;1(3):203-10.
1992: David Cella
Health promotion in oncology: a cancer wellness doctrine.
Journal of health care chaplaincy 1992;4(1-2):87-101.
1992: David Cella
Quality of life: the concept.
Journal of palliative care 1992;8(3):8-13.
1991: David Cella; E J Orav; Alice B Kornblith; Jimmie C Holland; Peter M Silberfarb; K W Lee; R L Comis; M Perry; R Cooper; LH Maurer
Socioeconomic status and cancer survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(8):1500-9.
1990: S M Mahon; David Cella; M I Donovan
Psychosocial adjustment to recurrent cancer.
Oncology nursing forum 1990;17(3 Suppl):47-52; discussion 53-4.
1990: David Cella; D S Tulsky
Measuring quality of life today: methodological aspects.
Oncology (Williston Park, N.Y.) 1990;4(5):29-38; discussion 69.
1990: Alice B Kornblith; J Anderson; David Cella; S Tross; E Zuckerman; E Cherin; E S Henderson; R B Weiss; M R Cooper; R T Silver
Quality of life assessment of Hodgkin's disease survivors: a model for cooperative clinical trials.
Oncology (Williston Park, N.Y.) 1990;4(5):93-101; discussion 104.
1990: David Cella; S M Mahon; M I Donovan
Cancer recurrence as a traumatic event.
Behavioral medicine (Washington, D.C.) 1990;16(1):15-22.
1989: Marian L Fitzgibbon; David Cella; G Humfleet; E Griffin; K Sheridan
Motor slowing in asymptomatic HIV infection.
Perceptual and motor skills 1989;68(3 Pt 2):1331-8.
1989: J Amchin; S Perry; A Manevitz; David Cella; D Miller
Interview assessment of critically Ill patients regarding resuscitation decisions. A case study in ethics research.
General hospital psychiatry 1989;11(2):103-8.
1988: Marian L Fitzgibbon; David Cella; John A Sweeney
Redundancy in measures of depression.
Journal of clinical psychology 1988;44(3):372-4.
1988: David Cella; E A Cherin
Quality of life during and after cancer treatment.
Comprehensive therapy 1988;14(5):69-75.
1988: David Cella; S W Perry; M E Poag; R Amand; C Goodwin
Depression and stress responses in parents of burned children.
Journal of pediatric psychology 1988;13(1):87-99.
1988: David Cella; S W Perry; S Kulchycky; C Goodwin
Stress and coping in relatives of burn patients: a longitudinal study.
Hospital & community psychiatry 1988;39(2):159-66.
1987: David Cella; B Orofiamma; Jimmie C Holland; Peter M Silberfarb; S Tross; M Feldstein; M Perry; LH Maurer; R Comis; E J Orav
The relationship of psychological distress, extent of disease, and performance status in patients with lung cancer.
Cancer 1987;60(7):1661-7.
1987: S W Perry; David Cella; J Falkenberg; G Heidrich; C Goodwin
Pain perception vs. pain response in burn patients.
The American journal of nursing 1987;87(5):698-9.
1987: S W Perry; David Cella
Overdiagnosis of depression in the medically ill.
The American journal of psychiatry 1987;144(1):125-6.
1987: David Cella; S Tross
Death anxiety in cancer survival: a preliminary cross-validation study.
Journal of personality assessment 1987;51(3):451-61.
1987: David Cella; Paul B Jacobsen; E J Orav; Jimmie C Holland; Peter M Silberfarb; S Rafla
A brief POMS measure of distress for cancer patients.
Journal of chronic diseases 1987;40(10):939-42.
1987: David Cella
Cancer survival: psychosocial and public issues.
Cancer investigation 1987;5(1):59-67.
1987: David Cella; A S DeWolfe; Marian L Fitzgibbon
Ego identity status, identification, and decision-making style in late adolescents.
Adolescence 1987;22(88):849-61.
1986: David Cella; S W Perry
Reliability and concurrent validity of three visual-analogue mood scales.
Psychological reports 1986;59(2 Pt 2):827-33.
1986: David Cella; S Tross
Psychological adjustment to survival from Hodgkin's disease.
Journal of consulting and clinical psychology 1986;54(5):616-22.
1986: David Cella; A Pratt; Jimmie C Holland
Persistent anticipatory nausea, vomiting, and anxiety in cured Hodgkin's disease patients after completion of chemotherapy.
The American journal of psychiatry 1986;143(5):641-3.
1985: S W Perry; David Cella
Missed diagnosis of organic mental syndromes in hospitalized medical patients.
The American journal of psychiatry 1985;142(4):525-6.
1984: David Cella
The modified WAIS-R: an extension and revision.
Journal of clinical psychology 1984;40(3):801-4.